SARS-CoV-2-Queries

compareViruses.rq

Ejemplos de código: curl

SPARQL

SELECT DISTINCT ?virus ?virusLabel ?work ?workLabel WITH {
  SELECT DISTINCT ?virus ?virus2 ?work WHERE {
    VALUES ?virus {
      wd:Q82069695 # SARS-CoV-2
      wd:Q16983360 # HKU1
      wd:Q16991954 # OC43
      wd:Q8351095  # NL63 
      wd:Q16983356 # 229E 
      wd:Q4902157  # MERS-CoV
      wd:Q278567   # SARS-CoV
    }
    ?virus2 wdt:P171+ wd:Q57751738 .
    ?work wdt:P921 ?virus, ?virus2 .
    FILTER ( ?virus != ?virus2 )
  }
} AS %ARTICLES WHERE {
  INCLUDE %ARTICLES
  SERVICE wikibase:label { bd:serviceParam wikibase:language "es,en". }
}
ORDER BY ?virusLabel ?virus ?workLabel ?work

ejecutar o editar

Resultados

virus work
Coronavirus Humana NL63 (edit) Attachment factor and receptor engagement of SARS coronavirus and human coronavirus NL63. (edit)
Coronavirus Humana NL63 (edit) Detection of the human coronavirus 229E, HKU1, NL63, and OC43 between 2010 and 2013 in Yamagata, Japan. (edit)
Coronavirus Humana NL63 (edit) Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. (edit)
Coronavirus Humana NL63 (edit) Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients. (edit)
Coronavirus Humana NL63 (edit) Human Coronaviruses HCoV-NL63 and HCoV-HKU1 in Hospitalized Children with Acute Respiratory Infections in Beijing, China. (edit)
Coronavirus Humana NL63 (edit) Inhibition of endoplasmic reticulum-resident glucosidases impairs severe acute respiratory syndrome coronavirus and human coronavirus NL63 spike protein-mediated entry by altering the glycan processing of angiotensin I-converting enzyme 2. (edit)
Coronavirus Humana NL63 (edit) Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease. (edit)
Coronavirus Humana NL63 (edit) Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506. (edit)
Coronavirus Humana NL63 (edit) SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. (edit)
Coronavirus Humana NL63 (edit) SARS-CoV, but not HCoV-NL63, utilizes cathepsins to infect cells: viral entry. (edit)
Coronavirus Humana NL63 (edit) The novel human coronaviruses NL63 and HKU1. (edit)
Coronavirus Humana NL63 (edit) [Development and comparison of real-time and conventional RT-PCR assay for detection of human coronavirus NL63 and HKU1]. (edit)
Human coronavirus 229E (edit) Biochemical and immunological studies of nucleocapsid proteins of severe acute respiratory syndrome and 229E human coronaviruses. (edit)
Human coronavirus 229E (edit) Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by SARS coronavirus and human coronavirus 229E. (edit)
Human coronavirus 229E (edit) Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by severe acute respiratory syndrome coronavirus and human coronavirus 229E. (edit)
Human coronavirus 229E (edit) Detection of the human coronavirus 229E, HKU1, NL63, and OC43 between 2010 and 2013 in Yamagata, Japan. (edit)
Human coronavirus 229E (edit) Exaggerated risk of transmission of COVID-19 by fomites (edit)
Human coronavirus 229E (edit) Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients. (edit)
Human coronavirus 229E (edit) Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease. (edit)
Human coronavirus 229E (edit) Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506. (edit)
Human coronavirus 229E (edit) The ADP-ribose-1''-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses. (edit)
Human coronavirus HKU1 (edit) Detection of the human coronavirus 229E, HKU1, NL63, and OC43 between 2010 and 2013 in Yamagata, Japan. (edit)
Human coronavirus HKU1 (edit) Human Coronaviruses HCoV-NL63 and HCoV-HKU1 in Hospitalized Children with Acute Respiratory Infections in Beijing, China. (edit)
Human coronavirus HKU1 (edit) The novel human coronaviruses NL63 and HKU1. (edit)
Human coronavirus HKU1 (edit) [Development and comparison of real-time and conventional RT-PCR assay for detection of human coronavirus NL63 and HKU1]. (edit)
Human coronavirus OC43 (edit) An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus. (edit)
Human coronavirus OC43 (edit) Characterization of human coronavirus OC43 and human coronavirus NL63 infections among hospitalized children <5 years of age. (edit)
Human coronavirus OC43 (edit) Chimeric exchange of coronavirus nsp5 proteases (3CLpro) identifies common and divergent regulatory determinants of protease activity (edit)
Human coronavirus OC43 (edit) Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populations (edit)
Human coronavirus OC43 (edit) Coronavirus isolates SK and SD from multiple sclerosis patients are serologically related to murine coronaviruses A59 and JHM and human coronavirus OC43, but not to human coronavirus 229E. (edit)
Human coronavirus OC43 (edit) Detection of the human coronavirus 229E, HKU1, NL63, and OC43 between 2010 and 2013 in Yamagata, Japan. (edit)
Human coronavirus OC43 (edit) Exaggerated risk of transmission of COVID-19 by fomites (edit)
Human coronavirus OC43 (edit) False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike p (edit)
Human coronavirus OC43 (edit) Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients. (edit)
Human coronavirus OC43 (edit) Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: a possible source of hospital-acquired infections (edit)
Human coronavirus OC43 (edit) The dominance of human coronavirus OC43 and NL63 infections in infants (edit)
MERS-CoV (edit) A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity (edit)
MERS-CoV (edit) Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond. (edit)
MERS-CoV (edit) Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs (edit)
MERS-CoV (edit) Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains (edit)
MERS-CoV (edit) Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes. (edit)
MERS-CoV (edit) Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV). (edit)
MERS-CoV (edit) Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines (edit)
MERS-CoV (edit) Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors. (edit)
MERS-CoV (edit) Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV (edit)
MERS-CoV (edit) Medusa's ugly head again: from SARS to MERS-CoV. (edit)
MERS-CoV (edit) Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease (edit)
MERS-CoV (edit) Middle East respiratory syndrome: SARS redux? (edit)
MERS-CoV (edit) Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV (edit)
MERS-CoV (edit) Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein. (edit)
MERS-CoV (edit) Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review (edit)
MERS-CoV (edit) Risks to healthcare workers with emerging diseases: lessons from MERS-CoV, Ebola, SARS, and avian flu. (edit)
MERS-CoV (edit) Sensitivity of SARS/MERS CoV to interferons and other drugs based on achievable serum concentrations in humans. (edit)
MERS-CoV (edit) T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV. (edit)
MERS-CoV (edit) TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection (edit)
MERS-CoV (edit) The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2 (edit)
MERS-CoV (edit) Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)--possible lessons from a systematic review of SARS-CoV therapy. (edit)
MERS-CoV (edit) Travel implications of emerging coronaviruses: SARS and MERS-CoV. (edit)
SARS coronavirus (edit) 1H, 13C and 15N resonance assignments of SARS-CoV main protease N-terminal domain. (edit)
SARS coronavirus (edit) 2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral activity against both hepatitis C virus (HCV) and SARS-associated coronavirus (SCV). (edit)
SARS coronavirus (edit) A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity (edit)
SARS coronavirus (edit) A 3D model of SARS_CoV 3CL proteinase and its inhibitors design by virtual screening. (edit)
SARS coronavirus (edit) A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. (edit)
SARS coronavirus (edit) A Novel Chemical Compound for Inhibition of SARS Coronavirus Helicase. (edit)
SARS coronavirus (edit) A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. (edit)
SARS coronavirus (edit) A chimeric multi-epitope DNA vaccine elicited specific antibody response against severe acute respiratory syndrome-associated coronavirus which attenuated the virulence of SARS-CoV in vitro. (edit)
SARS coronavirus (edit) A climatologic investigation of the SARS-CoV outbreak in Beijing, China. (edit)
SARS coronavirus (edit) A convenient cell fusion assay for the study of SARS-CoV entry and inhibition. (edit)
SARS coronavirus (edit) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury (edit)
SARS coronavirus (edit) A decade after SARS: strategies for controlling emerging coronaviruses (edit)
SARS coronavirus (edit) A dominant antigenic epitope on SARS-CoV spike protein identified by an avian single-chain variable fragment (scFv)-expressing phage. (edit)
SARS coronavirus (edit) A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses. (edit)
SARS coronavirus (edit) A facile inhibitor screening of SARS coronavirus N protein using nanoparticle-based RNA oligonucleotide (edit)
SARS coronavirus (edit) A fluorogenic peptide containing the processing site of human SARS corona virus S-protein: kinetic evaluation and NMR structure elucidation. (edit)
SARS coronavirus (edit) A genome sequence of novel SARS-CoV isolates: the genotype, GD-Ins29, leads to a hypothesis of viral transmission in South China. (edit)
SARS coronavirus (edit) A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2. (edit)
SARS coronavirus (edit) A human SARS-CoV neutralizing antibody against epitope on S2 protein. (edit)
SARS coronavirus (edit) A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection (edit)
SARS coronavirus (edit) A molecular docking model of SARS-CoV S1 protein in complex with its receptor, human ACE2. (edit)
SARS coronavirus (edit) A monomer-dimer nanoswitch that mimics the working principle of the SARS-CoV 3CLpro enzyme controls copper-catalysed cyclopropanation. (edit)
SARS coronavirus (edit) A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. (edit)
SARS coronavirus (edit) A network integration approach to predict conserved regulators related to pathogenicity of influenza and SARS-CoV respiratory viruses. (edit)
SARS coronavirus (edit) A new infectious disease challenge: Urbani severe acute respiratory syndrome (SARS) associated coronavirus. (edit)
SARS coronavirus (edit) A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo (edit)
SARS coronavirus (edit) A new nucleotide-composition based fingerprint of SARS-CoV with visualization analysis. (edit)
SARS coronavirus (edit) A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. (edit)
SARS coronavirus (edit) A novel cell-based binding assay system reconstituting interaction between SARS-CoV S protein and its cellular receptor. (edit)
SARS coronavirus (edit) A novel fingerprint map for detecting SARS-CoV. (edit)
SARS coronavirus (edit) A novel subset of putative stem/progenitor CD34+Oct-4+ cells is the major target for SARS coronavirus in human lung. (edit)
SARS coronavirus (edit) A one step quantitative RT-PCR for detection of SARS coronavirus with an internal control for PCR inhibitors. (edit)
SARS coronavirus (edit) A putative diacidic motif in the SARS-CoV ORF6 protein influences its subcellular localization and suppression of expression of co-transfected expression constructs. (edit)
SARS coronavirus (edit) A rapid point of care immunoswab assay for SARS-CoV detection. (edit)
SARS coronavirus (edit) A real-time PCR assay for bat SARS-like coronavirus detection and its application to Italian greater horseshoe bat faecal sample surveys. (edit)
SARS coronavirus (edit) A real-time PCR for SARS-coronavirus incorporating target gene pre-amplification (edit)
SARS coronavirus (edit) A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice. (edit)
SARS coronavirus (edit) A review of studies on animal reservoirs of the SARS coronavirus. (edit)
SARS coronavirus (edit) A simple and rapid approach for screening of SARS-coronavirus genotypes: an evaluation study (edit)
SARS coronavirus (edit) A single amino acid substitution in the S1 and S2 Spike protein domains determines the neutralization escape phenotype of SARS-CoV. (edit)
SARS coronavirus (edit) A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies (edit)
SARS coronavirus (edit) A strategy for searching antigenic regions in the SARS-CoV spike protein. (edit)
SARS coronavirus (edit) A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters (edit)
SARS coronavirus (edit) A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus. (edit)
SARS coronavirus (edit) A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice. (edit)
SARS coronavirus (edit) A three-stemmed mRNA pseudoknot in the SARS coronavirus frameshift signal (edit)
SARS coronavirus (edit) A throat lozenge containing amyl meta cresol and dichlorobenzyl alcohol has a direct virucidal effect on respiratory syncytial virus, influenza A and SARS-CoV (edit)
SARS coronavirus (edit) A universal microarray for detection of SARS coronavirus. (edit)
SARS coronavirus (edit) ACE2: from vasopeptidase to SARS virus receptor (edit)
SARS coronavirus (edit) Accelerated induction of apoptosis in insect cells by baculovirus-expressed SARS-CoV membrane protein. (edit)
SARS coronavirus (edit) Accumulation of recombinant SARS-CoV spike protein in plant cytosol and chloroplasts indicate potential for development of plant-derived oral vaccines. (edit)
SARS coronavirus (edit) Acquisition of new protein domains by coronaviruses: analysis of overlapping genes coding for proteins N and 9b in SARS coronavirus. (edit)
SARS coronavirus (edit) Adaptive evolution of the spike gene of SARS coronavirus: changes in positively selected sites in different epidemic groups (edit)
SARS coronavirus (edit) Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats. (edit)
SARS coronavirus (edit) Aetiology: Koch's postulates fulfilled for SARS virus. (edit)
SARS coronavirus (edit) Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model. (edit)
SARS coronavirus (edit) Allelic Variation in the Toll-Like Receptor Adaptor Protein Ticam2 Contributes to SARS-Coronavirus Pathogenesis in Mice. (edit)
SARS coronavirus (edit) Amino acids 1 to 422 of the spike protein of SARS associated coronavirus are required for induction of cyclooxygenase-2. (edit)
SARS coronavirus (edit) Amino acids 15-28 in the ectodomain of SARS coronavirus 3a protein induces neutralizing antibodies. (edit)
SARS coronavirus (edit) Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level. (edit)
SARS coronavirus (edit) An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus. (edit)
SARS coronavirus (edit) An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy. (edit)
SARS coronavirus (edit) An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus. (edit)
SARS coronavirus (edit) An atypical RNA pseudoknot stimulator and an upstream attenuation signal for -1 ribosomal frameshifting of SARS coronavirus. (edit)
SARS coronavirus (edit) An efficient RNA-cleaving DNA enzyme can specifically target the 5'-untranslated region of severe acute respiratory syndrome associated coronavirus (SARS-CoV). (edit)
SARS coronavirus (edit) An efficient method for the synthesis of peptide aldehyde libraries employed in the discovery of reversible SARS coronavirus main protease (SARS-CoV Mpro) inhibitors. (edit)
SARS coronavirus (edit) An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. (edit)
SARS coronavirus (edit) An immunosuppressed Syrian golden hamster model for SARS-CoV infection. (edit)
SARS coronavirus (edit) An initial investigation of the association between the SARS outbreak and weather: with the view of the environmental temperature and its variation. (edit)
SARS coronavirus (edit) An oral mucosal DNA vaccine for SARS coronavirus infections. (edit)
SARS coronavirus (edit) An overall picture of SARS coronavirus (SARS-CoV) genome-encoded major proteins: structures, functions and drug development. (edit)
SARS coronavirus (edit) Analysis of SARS-CoV receptor activity of ACE2 orthologs. (edit)
SARS coronavirus (edit) Analysis of synonymous codon usage in SARS Coronavirus and other viruses in the Nidovirales. (edit)
SARS coronavirus (edit) Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry. (edit)
SARS coronavirus (edit) Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus. (edit)
SARS coronavirus (edit) Animal coronavirus vaccines: lessons for SARS. (edit)
SARS coronavirus (edit) Animal models and vaccines for SARS-CoV infection. (edit)
SARS coronavirus (edit) Animal models for SARS and MERS coronaviruses (edit)
SARS coronavirus (edit) Animal origins of SARS coronavirus: possible links with the international trade in small carnivores. (edit)
SARS coronavirus (edit) Animal reservoirs for SARS-like coronavirus in southern China. (edit)
SARS coronavirus (edit) Animal-to-human SARS-associated coronavirus transmission? (edit)
SARS coronavirus (edit) Anti-HIV, anti-poxvirus, and anti-SARS activity of a nontoxic, acidic plant extract from the Trifollium species Secomet-V/anti-vac suggests that it contains a novel broad-spectrum antiviral. (edit)
SARS coronavirus (edit) Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. (edit)
SARS coronavirus (edit) Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts. (edit)
SARS coronavirus (edit) Anti-SARS coronavirus agents: a patent review (2008 - present). (edit)
SARS coronavirus (edit) Anti-SARS virus antibody responses against human SARS-associated coronavirus and animal SARS-associated coronavirus-like virus. (edit)
SARS coronavirus (edit) Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome. (edit)
SARS coronavirus (edit) Anti-SARS-CoV activity of nucleoside analogs having 6-chloropurine as a nucleobase. (edit)
SARS coronavirus (edit) Anti-SARS-CoV immunoglobulin G in healthcare workers, Guangzhou, China (edit)
SARS coronavirus (edit) Anti-frameshifting ligand reduces the conformational plasticity of the SARS virus pseudoknot. (edit)
SARS coronavirus (edit) Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro. (edit)
SARS coronavirus (edit) Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC. (edit)
SARS coronavirus (edit) Antibodies to SARS coronavirus in civets. (edit)
SARS coronavirus (edit) Antibodies to SARS-like virus hint at repeated infections. (edit)
SARS coronavirus (edit) Antibody binding site mapping of SARS-CoV spike protein receptor-binding domain by a combination of yeast surface display and phage peptide library screening. (edit)
SARS coronavirus (edit) Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection. (edit)
SARS coronavirus (edit) Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid. (edit)
SARS coronavirus (edit) Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals. (edit)
SARS coronavirus (edit) Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients. (edit)
SARS coronavirus (edit) Antibody responses to individual proteins of SARS coronavirus and their neutralization activities. (edit)
SARS coronavirus (edit) Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity. (edit)
SARS coronavirus (edit) Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins. (edit)
SARS coronavirus (edit) Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS. (edit)
SARS coronavirus (edit) Antibody-mediated synergy and interference in the neutralization of SARS-CoV at an epitope cluster on the spike protein. (edit)
SARS coronavirus (edit) Antigenic cross-reactivity between the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus and polyclonal antisera of antigenic group I animal coronaviruses: implication for SARS diagnosis. (edit)
SARS coronavirus (edit) Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells. (edit)
SARS coronavirus (edit) Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein. (edit)
SARS coronavirus (edit) Antisense downregulation of SARS-CoV gene expression in Vero E6 cells. (edit)
SARS coronavirus (edit) Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus. (edit)
SARS coronavirus (edit) Antiviral agents and corticosteroids in the treatment of severe acute respiratory syndrome (SARS). (edit)
SARS coronavirus (edit) Antiviral drug discovery against SARS-CoV. (edit)
SARS coronavirus (edit) Antiviral treatment of SARS: can we draw any conclusions? (edit)
SARS coronavirus (edit) Apoptosis induced by the SARS-associated coronavirus in Vero cells is replication-dependent and involves caspase. (edit)
SARS coronavirus (edit) Application of bioinformatics in search for cleavable peptides of SARS-CoV M(pro) and chemical modification of octapeptides. (edit)
SARS coronavirus (edit) Application of real-time PCR for testing antiviral compounds against Lassa virus, SARS coronavirus and Ebola virus in vitro. (edit)
SARS coronavirus (edit) Applying lessons from SARS to a newly identified coronavirus. (edit)
SARS coronavirus (edit) Assays for the assessment of neutralizing antibody activities against Severe Acute Respiratory Syndrome (SARS) associated coronavirus (SCV). (edit)
SARS coronavirus (edit) Assembling the SARS-CoV genome -- new method based on graph theoretical approach. (edit)
SARS coronavirus (edit) Asymptomatic SARS coronavirus infection among healthcare workers, Singapore. (edit)
SARS coronavirus (edit) Asymptomatic animal traders prove positive for SARS virus. (edit)
SARS coronavirus (edit) Attachment factor and receptor engagement of SARS coronavirus and human coronavirus NL63. (edit)
SARS coronavirus (edit) Attenuation of SARS coronavirus by a short hairpin RNA expression plasmid targeting RNA-dependent RNA polymerase. (edit)
SARS coronavirus (edit) Augmentation of immune responses to SARS coronavirus by a combination of DNA and whole killed virus vaccines. (edit)
SARS coronavirus (edit) Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)-associated coronavirus infection. (edit)
SARS coronavirus (edit) Automated extraction protocol for quantification of SARS-coronavirus RNA in serum: an evaluation study. (edit)
SARS coronavirus (edit) Baculovirus surface display of SARS coronavirus (SARS-CoV) spike protein and immunogenicity of the displayed protein in mice models. (edit)
SARS coronavirus (edit) Bat cave solves mystery of deadly SARS virus - and suggests new outbreak could occur. (edit)
SARS coronavirus (edit) Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond. (edit)
SARS coronavirus (edit) Bats and emerging zoonoses: henipaviruses and SARS. (edit)
SARS coronavirus (edit) Bats are natural reservoirs of SARS-like coronaviruses (edit)
SARS coronavirus (edit) Bats as animal reservoirs for the SARS coronavirus: hypothesis proved after 10 years of virus hunting. (edit)
SARS coronavirus (edit) Bcl-2 inhibits the caspase-dependent apoptosis induced by SARS-CoV without affecting virus replication kinetics. (edit)
SARS coronavirus (edit) Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition. (edit)
SARS coronavirus (edit) Binding interaction of SARS coronavirus 3CL(pro) protease with vacuolar-H+ ATPase G1 subunit. (edit)
SARS coronavirus (edit) Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. (edit)
SARS coronavirus (edit) Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. (edit)
SARS coronavirus (edit) Bioinformatics analysis of SARS coronavirus genome polymorphism (edit)
SARS coronavirus (edit) Bioinformatics research on the SARS coronavirus (SARS_CoV) in China. (edit)
SARS coronavirus (edit) Bioterrorism and emerging infectious disease - antimicrobials, therapeutics and immune-modulators. SARS coronavirus. (edit)
SARS coronavirus (edit) Bismuth complexes inhibit the SARS coronavirus. (edit)
SARS coronavirus (edit) Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice. (edit)
SARS coronavirus (edit) Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway (edit)
SARS coronavirus (edit) CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein. (edit)
SARS coronavirus (edit) Candidate genes associated with susceptibility for SARS-coronavirus. (edit)
SARS coronavirus (edit) Cell entry by enveloped viruses: redox considerations for HIV and SARS-coronavirus. (edit)
SARS coronavirus (edit) Cellular entry of the SARS coronavirus. (edit)
SARS coronavirus (edit) Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection. (edit)
SARS coronavirus (edit) Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. (edit)
SARS coronavirus (edit) Challenges presented by MERS corona virus, and SARS corona virus to global health (edit)
SARS coronavirus (edit) Changing virulence of the SARS virus: the epidemiological evidence. (edit)
SARS coronavirus (edit) Characterisation of animal angiotensin-converting enzyme 2 receptors and use of pseudotyped virus to correlate receptor binding with susceptibility of SARS-CoV infection. (edit)
SARS coronavirus (edit) Characterization and application of monoclonal antibodies against N protein of SARS-coronavirus. (edit)
SARS coronavirus (edit) Characterization and inhibition of SARS-coronavirus main protease. (edit)
SARS coronavirus (edit) Characterization of SARS-CoV main protease and identification of biologically active small molecule inhibitors using a continuous fluorescence-based assay. (edit)
SARS coronavirus (edit) Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection (edit)
SARS coronavirus (edit) Characterization of cytotoxic T-lymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD-integrin-binding motif. (edit)
SARS coronavirus (edit) Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments. (edit)
SARS coronavirus (edit) Characterization of monoclonal antibody against SARS coronavirus nucleocapsid antigen and development of an antigen capture ELISA. (edit)
SARS coronavirus (edit) Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV). (edit)
SARS coronavirus (edit) Characterization of persistent SARS-CoV infection in Vero E6 cells. (edit)
SARS coronavirus (edit) Characterization of protein-protein interactions between the nucleocapsid protein and membrane protein of the SARS coronavirus. (edit)
SARS coronavirus (edit) Characterization of the antiviral effects of interferon-alpha against a SARS-like coronoavirus infection in vitro. (edit)
SARS coronavirus (edit) Characterization of the heptad repeat regions, HR1 and HR2, and design of a fusion core structure model of the spike protein from severe acute respiratory syndrome (SARS) coronavirus. (edit)
SARS coronavirus (edit) Characterization of viral proteins encoded by the SARS-coronavirus genome. (edit)
SARS coronavirus (edit) Characterizing 56 complete SARS-CoV S-gene sequences from Hong Kong. (edit)
SARS coronavirus (edit) Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells. (edit)
SARS coronavirus (edit) Chicken single-chain variable fragments against the SARS-CoV spike protein. (edit)
SARS coronavirus (edit) Children's vaccines do not induce cross reactivity against SARS-CoV. (edit)
SARS coronavirus (edit) Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. (edit)
SARS coronavirus (edit) Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. (edit)
SARS coronavirus (edit) Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity (edit)
SARS coronavirus (edit) Clinical evaluation of real-time PCR assays for rapid diagnosis of SARS coronavirus during outbreak and post-epidemic periods. (edit)
SARS coronavirus (edit) Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. (edit)
SARS coronavirus (edit) Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy (edit)
SARS coronavirus (edit) Cloning, expression, and purification of the nucleocapsid protein of SARS coronavirus. (edit)
SARS coronavirus (edit) Cloning, sequencing, expression, and purification of SARS-associated coronavirus nucleocapsid protein for serodiagnosis of SARS. (edit)
SARS coronavirus (edit) Combination of functionalized nanoparticles and polymerase chain reaction-based method for SARS-CoV gene detection. (edit)
SARS coronavirus (edit) Comparative analysis of the SARS coronavirus genome: a good start to a long journey. (edit)
SARS coronavirus (edit) Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model. (edit)
SARS coronavirus (edit) Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. (edit)
SARS coronavirus (edit) Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by SARS coronavirus and human coronavirus 229E. (edit)
SARS coronavirus (edit) Comparative immunization in BALB/c mice with recombinant replication-defective adenovirus vector and DNA plasmid expressing a SARS-CoV nucleocapsid protein gene. (edit)
SARS coronavirus (edit) Comparative pathogenesis of three human and zoonotic SARS-CoV strains in cynomolgus macaques (edit)
SARS coronavirus (edit) Comparison of immunoglobulin G responses to the spike and nucleocapsid proteins of severe acute respiratory syndrome (SARS) coronavirus in patients with SARS (edit)
SARS coronavirus (edit) Complete genome sequences of the SARS-CoV: the BJ Group (Isolates BJ01-BJ04). (edit)
SARS coronavirus (edit) Comprehensive antibody epitope mapping of the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus: insight into the humoral immunity of SARS. (edit)
SARS coronavirus (edit) Comprehensive detection and identification of human coronaviruses, including the SARS-associated coronavirus, with a single RT-PCR assay. (edit)
SARS coronavirus (edit) Computational characterization and design of SARS coronavirus receptor recognition and antibody neutralization. (edit)
SARS coronavirus (edit) Concentration and detection of SARS coronavirus in sewage from Xiao Tang Shan Hospital and the 309th Hospital of the Chinese People's Liberation Army. (edit)
SARS coronavirus (edit) Concentration and detection of SARS coronavirus in sewage from Xiao Tang Shan Hospital and the 309th Hospital. (edit)
SARS coronavirus (edit) Conductance and amantadine binding of a pore formed by a lysine-flanked transmembrane domain of SARS coronavirus envelope protein. (edit)
SARS coronavirus (edit) Conference report - II. Investigating new vaccines: SARS. Highlights from the Viral Vaccine Meeting; October 25-28, 2003; Barcelona, Spain. (edit)
SARS coronavirus (edit) Construction of a eukaryotic expression plasmid encoding partial S gene fragments of the SARS-CoV and its potential utility as a DNA vaccine. (edit)
SARS coronavirus (edit) Construction of a non-infectious SARS coronavirus replicon for application in drug screening and analysis of viral protein function. (edit)
SARS coronavirus (edit) Coordinate induction of IFN-alpha and -gamma by SARS-CoV also in the absence of virus replication. (edit)
SARS coronavirus (edit) Copious production of SARS-CoV nucleocapsid protein employing codon optimized synthetic gene. (edit)
SARS coronavirus (edit) Coronaviridae and SARS-associated coronavirus strain HSR1. (edit)
SARS coronavirus (edit) Coronavirus 3CLpro proteinase cleavage sites: possible relevance to SARS virus pathology (edit)
SARS coronavirus (edit) Coronavirus in severe acute respiratory syndrome (SARS). (edit)
SARS coronavirus (edit) Coronavirus outbreak in cheetahs: lessons for SARS. (edit)
SARS coronavirus (edit) Coronavirus replication and pathogenesis: Implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development. (edit)
SARS coronavirus (edit) Coronaviruses post-SARS: update on replication and pathogenesis. (edit)
SARS coronavirus (edit) Correction: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus. (edit)
SARS coronavirus (edit) Correction: SARS Coronavirus 3b Accessory Protein Modulates Transcriptional Activity of RUNX1b. (edit)
SARS coronavirus (edit) Correction: Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants. (edit)
SARS coronavirus (edit) Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses. (edit)
SARS coronavirus (edit) Cross-reaction of SARS-CoV antigen with autoantibodies in autoimmune diseases. (edit)
SARS coronavirus (edit) Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests. (edit)
SARS coronavirus (edit) Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11. (edit)
SARS coronavirus (edit) Crystal structures reveal an induced-fit binding of a substrate-like Aza-peptide epoxide to SARS coronavirus main peptidase (edit)
SARS coronavirus (edit) Crystallization and diffraction analysis of the SARS coronavirus nsp10-nsp16 complex. (edit)
SARS coronavirus (edit) Crystallization and preliminary crystallographic analysis of the heptad-repeat complex of SARS coronavirus spike protein. (edit)
SARS coronavirus (edit) Cxcl16 interact with SARS-CoV N protein in and out cell. (edit)
SARS coronavirus (edit) Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections. (edit)
SARS coronavirus (edit) Date of origin of the SARS coronavirus strains (edit)
SARS coronavirus (edit) Deciphering the biosynthetic codes for the potent anti-SARS-CoV cyclodepsipeptide valinomycin in Streptomyces tsusimaensis ATCC 15141. (edit)
SARS coronavirus (edit) Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein. (edit)
SARS coronavirus (edit) Derivation of a novel SARS-coronavirus replicon cell line and its application for anti-SARS drug screening. (edit)
SARS coronavirus (edit) Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction. (edit)
SARS coronavirus (edit) Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease. (edit)
SARS coronavirus (edit) Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors. (edit)
SARS coronavirus (edit) Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety. (edit)
SARS coronavirus (edit) Design of recombinant protein-based SARS-CoV entry inhibitors targeting the heptad-repeat regions of the spike protein S2 domain. (edit)
SARS coronavirus (edit) Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors. (edit)
SARS coronavirus (edit) Design, synthesis and screening of antisense peptide based combinatorial peptide libraries towards an aromatic region of SARS-CoV. (edit)
SARS coronavirus (edit) Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: structure-activity relationship study. (edit)
SARS coronavirus (edit) Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease. (edit)
SARS coronavirus (edit) Detecting specific cytotoxic T lymphocytes against SARS-coronavirus with DimerX HLA-A2:Ig fusion protein. (edit)
SARS coronavirus (edit) Detection and monitoring of SARS coronavirus in the plasma and peripheral blood lymphocytes of patients with severe acute respiratory syndrome. (edit)
SARS coronavirus (edit) Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. (edit)
SARS coronavirus (edit) Detection of SARS coronavirus in humans and animals by conventional and quantitative (real time) reverse transcription polymerase chain reactions. (edit)
SARS coronavirus (edit) Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays. (edit)
SARS coronavirus (edit) Detection of SARS coronavirus in patients with suspected SARS (edit)
SARS coronavirus (edit) Detection of SARS coronavirus in plasma by real-time RT-PCR. (edit)
SARS coronavirus (edit) Detection of SARS coronavirus. (edit)
SARS coronavirus (edit) Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis (edit)
SARS coronavirus (edit) Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units. (edit)
SARS coronavirus (edit) Detection of antibodies against SARS-CoV in serum from SARS-infected donors with ELISA and Western blot. (edit)
SARS coronavirus (edit) Detection of novel SARS-like and other coronaviruses in bats from Kenya. (edit)
SARS coronavirus (edit) Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in sars patients by enzyme-linked immunosorbent assay. (edit)
SARS coronavirus (edit) Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia. (edit)
SARS coronavirus (edit) Determination and application of immunodominant regions of SARS coronavirus spike and nucleocapsid proteins recognized by sera from different animal species. (edit)
SARS coronavirus (edit) Determination of SARS-coronavirus by a microfluidic chip system. (edit)
SARS coronavirus (edit) Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus. (edit)
SARS coronavirus (edit) Development and evaluation of an efficient 3'-noncoding region based SARS coronavirus (SARS-CoV) RT-PCR assay for detection of SARS-CoV infections. (edit)
SARS coronavirus (edit) Development and evaluation of an enzyme-linked immunosorbent assay for detection of antibodies against the spike protein of SARS-coronavirus. (edit)
SARS coronavirus (edit) Development and validation of a high-throughput screen for inhibitors of SARS CoV and its application in screening of a 100,000-compound library. (edit)
SARS coronavirus (edit) Development of Taqman RT-nested PCR system for clinical SARS-CoV detection. (edit)
SARS coronavirus (edit) Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant. (edit)
SARS coronavirus (edit) Development of a chimeric DNA-RNA hammerhead ribozyme targeting SARS virus. (edit)
SARS coronavirus (edit) Development of a dose-response model for SARS coronavirus. (edit)
SARS coronavirus (edit) Development of a method for concentrating and purifying SARS coronavirus RNA by a magnetic bead capture system. (edit)
SARS coronavirus (edit) Development of a molecular-beacon-based multi-allelic real-time RT-PCR assay for the detection of human coronavirus causing severe acute respiratory syndrome (SARS-CoV): a general methodology for detecting rapidly mutating viruses. (edit)
SARS coronavirus (edit) Development of a quantitative assay for SARS coronavirus and correlation of GAPDH mRNA with SARS coronavirus in clinical specimens (edit)
SARS coronavirus (edit) Development of a red-shifted fluorescence-based assay for SARS-coronavirus 3CL protease: identification of a novel class of anti-SARS agents from the tropical marine sponge Axinella corrugata. (edit)
SARS coronavirus (edit) Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein. (edit)
SARS coronavirus (edit) Development of a single nucleotide polymorphism DNA microarray for the detection and genotyping of the SARS coronavirus. (edit)
SARS coronavirus (edit) Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus (edit)
SARS coronavirus (edit) Development of chemical inhibitors of the SARS coronavirus: viral helicase as a potential target. (edit)
SARS coronavirus (edit) Development of human single-chain antibodies against SARS-associated coronavirus. (edit)
SARS coronavirus (edit) Development of mouse hepatitis virus and SARS-CoV infectious cDNA constructs. (edit)
SARS coronavirus (edit) Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: design, synthesis, biological evaluation, and docking studies. (edit)
SARS coronavirus (edit) Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models. (edit)
SARS coronavirus (edit) Diagnosis of severe acute respiratory syndrome (SARS) by detection of SARS coronavirus nucleocapsid antibodies in an antigen-capturing enzyme-linked immunosorbent assay (edit)
SARS coronavirus (edit) Diagnostics of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid antigen using chicken immunoglobulin Y. (edit)
SARS coronavirus (edit) Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava. (edit)
SARS coronavirus (edit) Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin. (edit)
SARS coronavirus (edit) Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2. (edit)
SARS coronavirus (edit) Differential characteristics of the early stage of lung inflammation induced by SARS-CoV Nucleocapsid protein related to age in the mouse. (edit)
SARS coronavirus (edit) Differential inhibitory activities and stabilisation of DNA aptamers against the SARS coronavirus helicase. (edit)
SARS coronavirus (edit) Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. (edit)
SARS coronavirus (edit) Differential stepwise evolution of SARS coronavirus functional proteins in different host species (edit)
SARS coronavirus (edit) Diffuse alveolar lesion in BALB/c mice induced with human reovirus BYD1 strain and its potential relation with SARS. (edit)
SARS coronavirus (edit) Direct sequencing of SARS-coronavirus S and N genes from clinical specimens shows limited variation. (edit)
SARS coronavirus (edit) Direct template matching reveals a host subcellular membrane gyroid cubic structure that is associated with SARS virus. (edit)
SARS coronavirus (edit) Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding (edit)
SARS coronavirus (edit) Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus. (edit)
SARS coronavirus (edit) Discovery of unsymmetrical aromatic disulfides as novel inhibitors of SARS-CoV main protease: Chemical synthesis, biological evaluation, molecular docking and 3D-QSAR study. (edit)
SARS coronavirus (edit) Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) (edit)
SARS coronavirus (edit) Dissection of the fusion machine of SARS-coronavirus. (edit)
SARS coronavirus (edit) Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus (edit)
SARS coronavirus (edit) Domestic poultry and SARS coronavirus, southern China (edit)
SARS coronavirus (edit) Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum. (edit)
SARS coronavirus (edit) Drug targets in severe acute respiratory syndrome (SARS) virus and other coronavirus infections. (edit)
SARS coronavirus (edit) Dynamic changes of serum SARS-coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge (edit)
SARS coronavirus (edit) Dynamics of SARS-coronavirus HR2 domain in the prefusion and transition states. (edit)
SARS coronavirus (edit) Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. (edit)
SARS coronavirus (edit) Early detection of antibodies against various structural proteins of the SARS-associated coronavirus in SARS patients. (edit)
SARS coronavirus (edit) Early diagnosis of SARS coronavirus infection by real time RT-PCR. (edit)
SARS coronavirus (edit) Early events of SARS coronavirus infection in vero cells. (edit)
SARS coronavirus (edit) Early gene expression events in ferrets in response to SARS coronavirus infection versus direct interferon-alpha2b stimulation. (edit)
SARS coronavirus (edit) Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS. (edit)
SARS coronavirus (edit) Effects of a SARS-associated coronavirus vaccine in monkeys. (edit)
SARS coronavirus (edit) Effects of different immunization protocols and adjuvant on antibody responses to inactivated SARS-CoV vaccine. (edit)
SARS coronavirus (edit) Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients. (edit)
SARS coronavirus (edit) Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets. (edit)
SARS coronavirus (edit) Efficacy of various disinfectants against SARS coronavirus. (edit)
SARS coronavirus (edit) Efficient and quick inactivation of SARS coronavirus and other microbes exposed to the surfaces of some metal catalysts. (edit)
SARS coronavirus (edit) Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system. (edit)
SARS coronavirus (edit) Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (SARS)-associated coronavirus by immunization with surface-linked liposomal peptides derived from a non-structural polyprotein 1a. (edit)
SARS coronavirus (edit) Elevated plasma surfactant protein D (SP-D) levels and a direct correlation with anti-severe acute respiratory syndrome coronavirus-specific IgG antibody in SARS patients. (edit)
SARS coronavirus (edit) Emergency medical services utilization during an outbreak of severe acute respiratory syndrome (SARS) and the incidence of SARS-associated coronavirus infection among emergency medical technicians. (edit)
SARS coronavirus (edit) Emodin inhibits current through SARS-associated coronavirus 3a protein. (edit)
SARS coronavirus (edit) Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2. (edit)
SARS coronavirus (edit) Enhancement of SARS-CoV infection by proteases. (edit)
SARS coronavirus (edit) Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin. (edit)
SARS coronavirus (edit) Enhancing immune responses against SARS-CoV nucleocapsid DNA vaccine by co-inoculating interleukin-2 expressing vector in mice. (edit)
SARS coronavirus (edit) Environmental and occupational health response to SARS, Taiwan, 2003 (edit)
SARS coronavirus (edit) Environmental transmission of SARS at Amoy Gardens. (edit)
SARS coronavirus (edit) Erratum to: Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode. (edit)
SARS coronavirus (edit) Essential covalent linkage between the chymotrypsin-like domain and the extra domain of the SARS-CoV main protease. (edit)
SARS coronavirus (edit) Establishment and characterization of monoclonal antibodies against SARS coronavirus. (edit)
SARS coronavirus (edit) Establishment of a fluorescent polymerase chain reaction method for the detection of the SARS-associated coronavirus and its clinical application. (edit)
SARS coronavirus (edit) Establishment of the eukaryotic cell lines for inducible control of SARS-CoV nucleocapsid gene expression. (edit)
SARS coronavirus (edit) Evaluating the 3C-like protease activity of SARS-Coronavirus: recommendations for standardized assays for drug discovery. (edit)
SARS coronavirus (edit) Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine. (edit)
SARS coronavirus (edit) Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV. (edit)
SARS coronavirus (edit) Evaluation of a peptide-based enzyme immunoassay for anti-SARS coronavirus IgG antibody. (edit)
SARS coronavirus (edit) Evaluation of a real-time polymerase-chain reaction for severe acute respiratory syndrome (SARS) associated coronavirus in patients with hospitalised exacerbation of COPD. (edit)
SARS coronavirus (edit) Evaluation of a recombinant nucleocapsid protein-based assay for anti-SARS-CoV IgG detection. (edit)
SARS coronavirus (edit) Evaluation of a safe and sensitive Spike protein-based immunofluorescence assay for the detection of antibody responses to SARS-CoV. (edit)
SARS coronavirus (edit) Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA. (edit)
SARS coronavirus (edit) Evaluation of homology modeling of the severe acute respiratory syndrome (SARS) coronavirus main protease for structure based drug design. (edit)
SARS coronavirus (edit) Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV. (edit)
SARS coronavirus (edit) Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets. (edit)
SARS coronavirus (edit) Evaluation of the safety, immunogenicity and pharmacokinetics of equine anti-SARS-CoV F(ab')(2) in macaque. (edit)
SARS coronavirus (edit) Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice. (edit)
SARS coronavirus (edit) Evidence for substrate binding-induced zwitterion formation in the catalytic Cys-His dyad of the SARS-CoV main protease. (edit)
SARS coronavirus (edit) Evidence from the evolutionary analysis of nucleotide sequences for a recombinant history of SARS-CoV. (edit)
SARS coronavirus (edit) Evidence of the recombinant origin of a bat severe acute respiratory syndrome (SARS)-like coronavirus and its implications on the direct ancestor of SARS coronavirus. (edit)
SARS coronavirus (edit) Evolution and variation of the SARS-CoV genome. (edit)
SARS coronavirus (edit) Evolutional insights on uncharacterized SARS coronavirus genes. (edit)
SARS coronavirus (edit) Excretion and detection of SARS coronavirus and its nucleic acid from digestive system (edit)
SARS coronavirus (edit) Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies. (edit)
SARS coronavirus (edit) Expanding the frontiers of existing antiviral drugs: possible effects of HIV-1 protease inhibitors against SARS and avian influenza. (edit)
SARS coronavirus (edit) Experiences and implications of social workers practicing in a pediatric hospital environment affected by SARS. (edit)
SARS coronavirus (edit) Exploring the binding mechanism of the main proteinase in SARS-associated coronavirus and its implication to anti-SARS drug design. (edit)
SARS coronavirus (edit) Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2). (edit)
SARS coronavirus (edit) Expression and characterization of recombinant S2 subunit of SARS-coronavirus S fusion protein. (edit)
SARS coronavirus (edit) Expression and functional characterisation of the putative SARS coronavirus non-structural proteins X1-X5. (edit)
SARS coronavirus (edit) Expression and purification of N and E proteins from severe acute respiratory syndrome (SARS)-associated coronavirus: a comparative study. (edit)
SARS coronavirus (edit) Expression and purification of SARS coronavirus membrane protein. (edit)
SARS coronavirus (edit) Expression and purification of SARS coronavirus proteins using SUMO-fusions. (edit)
SARS coronavirus (edit) Expression cloning of functional receptor used by SARS coronavirus. (edit)
SARS coronavirus (edit) Expression of SARS-coronavirus envelope protein in Escherichia coli cells alters membrane permeability. (edit)
SARS coronavirus (edit) Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination. (edit)
SARS coronavirus (edit) Expression of SARS-coronavirus spike glycoprotein in Pichia pastoris. (edit)
SARS coronavirus (edit) Expression of feline angiotensin converting enzyme 2 and its interaction with SARS-CoV S1 protein. (edit)
SARS coronavirus (edit) Expression, crystallization and preliminary crystallographic study of the C-terminal half of nsp2 from SARS coronavirus. (edit)
SARS coronavirus (edit) Expression, purification and crystallization of the SARS-CoV macro domain. (edit)
SARS coronavirus (edit) Expression, purification and sublocalization of SARS-CoV nucleocapsid protein in insect cells. (edit)
SARS coronavirus (edit) Expression, purification, and characterization of SARS coronavirus RNA polymerase. (edit)
SARS coronavirus (edit) Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response. (edit)
SARS coronavirus (edit) Ezrin interacts with the SARS coronavirus Spike protein and restrains infection at the entry stage (edit)
SARS coronavirus (edit) Factors associated with nosocomial SARS-CoV transmission among healthcare workers in Hanoi, Vietnam, 2003 (edit)
SARS coronavirus (edit) False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike p (edit)
SARS coronavirus (edit) False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid-based western blot assay were rectified by the use of two subunits (S1 and S2) of spike for detection of antibody to SARS-CoV. (edit)
SARS coronavirus (edit) Features discriminating SARS from other severe viral respiratory tract infections. (edit)
SARS coronavirus (edit) First external quality assurance of antibody diagnostic for SARS-new coronavirus. (edit)
SARS coronavirus (edit) Folding of the SARS coronavirus spike glycoprotein immunological fragment (SARS_S1b): thermodynamic and kinetic investigation correlating with three-dimensional structural modeling. (edit)
SARS coronavirus (edit) Formalin-treated UV-inactivated SARS coronavirus vaccine retains its immunogenicity and promotes Th2-type immune responses. (edit)
SARS coronavirus (edit) From SARS coronavirus to novel animal and human coronaviruses. (edit)
SARS coronavirus (edit) From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses. (edit)
SARS coronavirus (edit) From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design (edit)
SARS coronavirus (edit) From genome to antivirals: SARS as a test tube. (edit)
SARS coronavirus (edit) From genome to drug lead: identification of a small-molecule inhibitor of the SARS virus. (edit)
SARS coronavirus (edit) Fully human monoclonal antibody directed to proteolytic cleavage site in severe acute respiratory syndrome (SARS) coronavirus S protein neutralizes the virus in a rhesus macaque SARS model. (edit)
SARS coronavirus (edit) Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): in search of potent SARS-CoV entry inhibitors. (edit)
SARS coronavirus (edit) Future antivirals-SMi conference: latest developments in HIV, hepatitis, herpes, influenza, RSV and SARS. (edit)
SARS coronavirus (edit) G0/G1 arrest and apoptosis induced by SARS-CoV 3b protein in transfected cells (edit)
SARS coronavirus (edit) Generating stable Chinese hamster ovary cell clones to produce a truncated SARS-CoV spike protein for vaccine development. (edit)
SARS coronavirus (edit) Generation of human antibody fragments recognizing distinct epitopes of the nucleocapsid (N) SARS-CoV protein using a phage display approach (edit)
SARS coronavirus (edit) Generation of predictive pharmacophore model for SARS-coronavirus main proteinase. (edit)
SARS coronavirus (edit) Genetic variation of SARS coronavirus in Beijing Hospital. (edit)
SARS coronavirus (edit) Genetic variation of the human α-2-Heremans-Schmid glycoprotein (AHSG) gene associated with the risk of SARS-CoV infection. (edit)
SARS coronavirus (edit) Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross. (edit)
SARS coronavirus (edit) Genome organization of the SARS-CoV (edit)
SARS coronavirus (edit) Genomic analysis and geographic visualization of H5N1 and SARS-CoV. (edit)
SARS coronavirus (edit) Genomic classification using an information-based similarity index: application to the SARS coronavirus. (edit)
SARS coronavirus (edit) Genosensor on gold films with enzymatic electrochemical detection of a SARS virus sequence. (edit)
SARS coronavirus (edit) Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa. (edit)
SARS coronavirus (edit) Getting ready for SARS. Officials consider tough measures to contain outbreaks should deadly virus return. (edit)
SARS coronavirus (edit) Global virus alert. How SARS highlighted the risk of viral pandemics. (edit)
SARS coronavirus (edit) Glycan arrays lead to the discovery of autoimmunogenic activity of SARS-CoV. (edit)
SARS coronavirus (edit) Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. (edit)
SARS coronavirus (edit) Growth kinetics of SARS-coronavirus in Vero E6 cells. (edit)
SARS coronavirus (edit) HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus. (edit)
SARS coronavirus (edit) HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins. (edit)
SARS coronavirus (edit) Heat sensitivity of a SARS-associated coronavirus introduced into plasma products. (edit)
SARS coronavirus (edit) Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus. (edit)
SARS coronavirus (edit) Heterologous expression of SARS-CoV ORF10 and X5 genes in E. coli and Streptomyces lividans TK24. (edit)
SARS coronavirus (edit) Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS. (edit)
SARS coronavirus (edit) High expression level of soluble SARS spike protein mediated by adenovirus in HEK293 cells (edit)
SARS coronavirus (edit) High-dose hydrocortisone reduces expression of the pro-inflammatory chemokines CXCL8 and CXCL10 in SARS coronavirus-infected intestinal cells. (edit)
SARS coronavirus (edit) High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery. (edit)
SARS coronavirus (edit) High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase. (edit)
SARS coronavirus (edit) High-yield expression of recombinant SARS coronavirus nucleocapsid protein in methylotrophic yeast Pichia pastoris. (edit)
SARS coronavirus (edit) Highly attenuated vaccinia virus DIs as a potential SARS vaccine. (edit)
SARS coronavirus (edit) Highly infectious SARS-CoV pseudotyped virus reveals the cell tropism and its correlation with receptor expression. (edit)
SARS coronavirus (edit) Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection. (edit)
SARS coronavirus (edit) Hong Kong health chief falls ill with suspected SARS virus. (edit)
SARS coronavirus (edit) How China’s ‘Bat Woman’ Hunted Down Viruses from SARS to the New Coronavirus (edit)
SARS coronavirus (edit) How change of public transportation usage reveals fear of the SARS virus in a city (edit)
SARS coronavirus (edit) How the SARS coronavirus causes disease: host or organism? (edit)
SARS coronavirus (edit) Human CD4(+) memory T-lymphocyte responses to SARS coronavirus infection. (edit)
SARS coronavirus (edit) Human SARS-coronavirus RNA-dependent RNA polymerase: activity determinants and nucleoside analogue inhibitors. (edit)
SARS coronavirus (edit) Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines (edit)
SARS coronavirus (edit) Human memory T cell responses to SARS-CoV E protein. (edit)
SARS coronavirus (edit) Human metapneumovirus-associated atypical pneumonia and SARS. (edit)
SARS coronavirus (edit) Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing (edit)
SARS coronavirus (edit) Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. (edit)
SARS coronavirus (edit) Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants (edit)
SARS coronavirus (edit) Human severe acute respiratory syndrome (SARS) and feline coronaviroses. (edit)
SARS coronavirus (edit) Humoral and cellular immune responses induced by 3a DNA vaccines against severe acute respiratory syndrome (SARS) or SARS-like coronavirus in mice. (edit)
SARS coronavirus (edit) Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine. (edit)
SARS coronavirus (edit) Identification and characterization of three novel small interference RNAs that effectively down-regulate the isolated nucleocapsid gene expression of SARS coronavirus. (edit)
SARS coronavirus (edit) Identification of SARS-like coronaviruses in horseshoe bats (Rhinolophus hipposideros) in Slovenia. (edit)
SARS coronavirus (edit) Identification of a B-cell antigenic epitope at the N-terminus of SARS-CoV M protein and characterization of monoclonal antibody against the protein. (edit)
SARS coronavirus (edit) Identification of a Novel Small Molecule Inhibitor Against SARS Coronavirus Helicase. (edit)
SARS coronavirus (edit) Identification of a new region of SARS-CoV S protein critical for viral entry (edit)
SARS coronavirus (edit) Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV. (edit)
SARS coronavirus (edit) Identification of a novel transcriptional repressor (HEPIS) that interacts with nsp-10 of SARS coronavirus. (edit)
SARS coronavirus (edit) Identification of an HLA-A*0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein. (edit)
SARS coronavirus (edit) Identification of an epitope of SARS-coronavirus nucleocapsid protein. (edit)
SARS coronavirus (edit) Identification of effective siRNA blocking the expression of SARS viral envelope E and RDRP genes. (edit)
SARS coronavirus (edit) Identification of essential genes as a strategy to select a SARS candidate vaccine using a SARS-CoV infectious cDNA. (edit)
SARS coronavirus (edit) Identification of ferret ACE2 and its receptor function for SARS-coronavirus. (edit)
SARS coronavirus (edit) Identification of human cell line model of persistent SARS coronavirus infection and studies of the response to cytokines and chemokines. (edit)
SARS coronavirus (edit) Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines. (edit)
SARS coronavirus (edit) Identification of immunogenic determinants of the spike protein of SARS-like coronavirus. (edit)
SARS coronavirus (edit) Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein. (edit)
SARS coronavirus (edit) Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13. (edit)
SARS coronavirus (edit) Identification of natural compounds with antiviral activities against SARS-associated coronavirus. (edit)
SARS coronavirus (edit) Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings (edit)
SARS coronavirus (edit) Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro. (edit)
SARS coronavirus (edit) Identification of probable genomic packaging signal sequence from SARS-CoV genome by bioinformatics analysis (edit)
SARS coronavirus (edit) Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro. (edit)
SARS coronavirus (edit) Identification of single-chain antibody fragments specific against SARS-associated coronavirus from phage-displayed antibody library. (edit)
SARS coronavirus (edit) Identification of the Mechanisms Causing Reversion to Virulence in an Attenuated SARS-CoV for the Design of a Genetically Stable Vaccine. (edit)
SARS coronavirus (edit) Identification of two antigenic epitopes on SARS-CoV spike protein. (edit)
SARS coronavirus (edit) Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors. (edit)
SARS coronavirus (edit) Identifying a killer: SARS virus. (edit)
SARS coronavirus (edit) Identifying inhibitors of the SARS coronavirus proteinase. (edit)
SARS coronavirus (edit) Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine. (edit)
SARS coronavirus (edit) Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated vaccine prepared from F69 strain. (edit)
SARS coronavirus (edit) Immune responses to T-cell epitopes of SARS CoV-N protein are enhanced by N immunization with a chimera of lysosome-associated membrane protein. (edit)
SARS coronavirus (edit) Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus. (edit)
SARS coronavirus (edit) Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses. (edit)
SARS coronavirus (edit) Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates. (edit)
SARS coronavirus (edit) Immunofluorescence assay for detection of the nucleocapsid antigen of the severe acute respiratory syndrome (SARS)-associated coronavirus in cells derived from throat wash samples of patients with SARS. (edit)
SARS coronavirus (edit) Immunogenicity and protection efficacy of monomeric and trimeric recombinant SARS coronavirus spike protein subunit vaccine candidates (edit)
SARS coronavirus (edit) Immunogenicity and protective efficacy in mice and hamsters of a β-propiolactone inactivated whole virus SARS-CoV vaccine (edit)
SARS coronavirus (edit) Immunogenicity difference between the SARS coronavirus and the bat SARS-like coronavirus spike (S) proteins. (edit)
SARS coronavirus (edit) Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice: implications for a subunit vaccine. (edit)
SARS coronavirus (edit) Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys. (edit)
SARS coronavirus (edit) Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan. (edit)
SARS coronavirus (edit) Immunological responses against SARS-coronavirus infection in humans. (edit)
SARS coronavirus (edit) Immunological, structural, and preliminary X-ray diffraction characterizations of the fusion core of the SARS-coronavirus spike protein. (edit)
SARS coronavirus (edit) Immunopathogenesis of coronavirus infections: implications for SARS. (edit)
SARS coronavirus (edit) Importance of Akt signaling pathway for apoptosis in SARS-CoV-infected Vero E6 cells. (edit)
SARS coronavirus (edit) Importance of SARS-CoV spike protein Trp-rich region in viral infectivity. (edit)
SARS coronavirus (edit) Improved prediction of MHC class I binders/non-binders peptides through artificial neural network using variable learning rate: SARS corona virus, a case study. (edit)
SARS coronavirus (edit) In Vitro Antiviral Activity of some Novel Isatin Derivatives against HCV and SARS-CoV Viruses. (edit)
SARS coronavirus (edit) In silico prediction of SARS protease inhibitors by virtual high throughput screening. (edit)
SARS coronavirus (edit) In vitro anti-hepatitis B and SARS virus activities of a titanium-substituted-heteropolytungstate. (edit)
SARS coronavirus (edit) In vitro biochemical and thermodynamic characterization of nucleocapsid protein of SARS. (edit)
SARS coronavirus (edit) In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. (edit)
SARS coronavirus (edit) Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry. (edit)
SARS coronavirus (edit) Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB/c mice. (edit)
SARS coronavirus (edit) Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents. (edit)
SARS coronavirus (edit) Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions, and chemical reagents. (edit)
SARS coronavirus (edit) Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. (edit)
SARS coronavirus (edit) Increase of SARS-CoV 3CL peptidase activity due to macromolecular crowding effects in the milieu composition. (edit)
SARS coronavirus (edit) Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons. (edit)
SARS coronavirus (edit) Indomethacin has a potent antiviral activity against SARS coronavirus (edit)
SARS coronavirus (edit) Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice. (edit)
SARS coronavirus (edit) Induction of interferon-gamma-inducible protein 10 by SARS-CoV infection, interferon alfacon 1 and interferon inducer in human bronchial epithelial Calu-3 cells and BALB/c mice. (edit)
SARS coronavirus (edit) Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses. (edit)
SARS coronavirus (edit) Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs. (edit)
SARS coronavirus (edit) Infection of human airway epithelia by SARS coronavirus is associated with ACE2 expression and localization (edit)
SARS coronavirus (edit) Infectious diseases. One year after outbreak, SARS virus yields some secrets. (edit)
SARS coronavirus (edit) Influence of HLA gene polymorphisms on susceptibility and outcome post infection with the SARS-CoV virus. (edit)
SARS coronavirus (edit) Influence of hydrophobic and electrostatic residues on SARS-coronavirus S2 protein stability: insights into mechanisms of general viral fusion and inhibitor design. (edit)
SARS coronavirus (edit) Influence of intron and exon splicing enhancers on mammalian cell expression of a truncated spike protein of SARS-CoV and its implication for subunit vaccine development. (edit)
SARS coronavirus (edit) Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts (edit)
SARS coronavirus (edit) Influenza and SARS: the impact of viral pandemics on maritime health. (edit)
SARS coronavirus (edit) Influenza as a model system for studying the cross-species transfer and evolution of the SARS coronavirus. (edit)
SARS coronavirus (edit) Inhibition of SARS coronavirus helicase by bismuth complexes. (edit)
SARS coronavirus (edit) Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs. (edit)
SARS coronavirus (edit) Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. (edit)
SARS coronavirus (edit) Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3'-digallate (TF3) (edit)
SARS coronavirus (edit) Inhibition of SARS-CoV gene expression by adenovirus-delivered small hairpin RNA. (edit)
SARS coronavirus (edit) Inhibition of SARS-CoV replication by siRNA. (edit)
SARS coronavirus (edit) Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a/7b, 3a/3b and S. (edit)
SARS coronavirus (edit) Inhibition of SARS-associated coronavirus infection and replication by RNA interference. (edit)
SARS coronavirus (edit) Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound. (edit)
SARS coronavirus (edit) Inhibition of cell proliferation by SARS-CoV infection in Vero E6 cells. (edit)
SARS coronavirus (edit) Inhibition of cytokine gene expression and induction of chemokine genes in non-lymphatic cells infected with SARS coronavirus. (edit)
SARS coronavirus (edit) Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics. (edit)
SARS coronavirus (edit) Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs. (edit)
SARS coronavirus (edit) Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin. (edit)
SARS coronavirus (edit) Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein. (edit)
SARS coronavirus (edit) Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies. (edit)
SARS coronavirus (edit) Inhibitor design for SARS coronavirus main protease based on "distorted key theory". (edit)
SARS coronavirus (edit) Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV (edit)
SARS coronavirus (edit) Inhibitors of SARS-3CLpro: virtual screening, biological evaluation, and molecular dynamics simulation studies. (edit)
SARS coronavirus (edit) Inhibitors of SARS-CoV entry--identification using an internally-controlled dual envelope pseudovirion assay. (edit)
SARS coronavirus (edit) Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus. (edit)
SARS coronavirus (edit) Initial viral load and the outcomes of SARS. (edit)
SARS coronavirus (edit) Insights from the association of SARS-CoV S-protein with its receptor, ACE2. (edit)
SARS coronavirus (edit) Insurance and epidemics: SARS, West Nile virus and Nipah virus. (edit)
SARS coronavirus (edit) Interaction between SARS-CoV helicase and a multifunctional cellular protein (Ddx5) revealed by yeast and mammalian cell two-hybrid systems (edit)
SARS coronavirus (edit) Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. (edit)
SARS coronavirus (edit) Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response. (edit)
SARS coronavirus (edit) Interaction of a peptide corresponding to the loop domain of the S2 SARS-CoV virus protein with model membranes. (edit)
SARS coronavirus (edit) Interactions among SARS-CoV accessory proteins revealed by bimolecular fluorescence complementation assay. (edit)
SARS coronavirus (edit) Interactions between SARS coronavirus and its receptor. (edit)
SARS coronavirus (edit) Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells. (edit)
SARS coronavirus (edit) Interferon alfacon1 is an inhibitor of SARS-corona virus in cell-based models. (edit)
SARS coronavirus (edit) Interferon and cytokine responses to SARS-coronavirus infection. (edit)
SARS coronavirus (edit) Interferon interplay helps tissue cells to cope with SARS-coronavirus infection. (edit)
SARS coronavirus (edit) Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation (edit)
SARS coronavirus (edit) Interferon-beta 1a and SARS coronavirus replication. (edit)
SARS coronavirus (edit) Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV). (edit)
SARS coronavirus (edit) Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells. (edit)
SARS coronavirus (edit) International research networks in viral structural proteomics: again, lessons from SARS. (edit)
SARS coronavirus (edit) Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in mice. (edit)
SARS coronavirus (edit) Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses. (edit)
SARS coronavirus (edit) Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against (edit)
SARS coronavirus (edit) Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans. (edit)
SARS coronavirus (edit) Investigation of immunogenic T-cell epitopes in SARS virus nucleocapsid protein and their role in the prevention and treatment of SARS infection. (edit)
SARS coronavirus (edit) Investigation of interaction between two neutralizing monoclonal antibodies and SARS virus using biosensor based on imaging ellipsometry. (edit)
SARS coronavirus (edit) Investigation of interactions between two monoclonal antibodies and SARS virus with a Label-free Protein Array. (edit)
SARS coronavirus (edit) Investigation of the pharmacophore space of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) NTPase/helicase by dihydroxychromone derivatives. (edit)
SARS coronavirus (edit) Is serum in childhood naturally protective against SARS-coronavirus? (edit)
SARS coronavirus (edit) Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? Lack of efficacy of promazine on SARS-CoV replication in a mouse model (edit)
SARS coronavirus (edit) Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? (edit)
SARS coronavirus (edit) Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor (edit)
SARS coronavirus (edit) Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China (edit)
SARS coronavirus (edit) Isolation and identification of an scFv antibody against nucleocapsid protein of SARS-CoV. (edit)
SARS coronavirus (edit) Isolation of inhibitory RNA aptamers against severe acute respiratory syndrome (SARS) coronavirus NTPase/Helicase. (edit)
SARS coronavirus (edit) Isolation of virus from a SARS patient and genome-wide analysis of genetic mutations related to pathogenesis and epidemiology from 47 SARS-CoV isolates. (edit)
SARS coronavirus (edit) JNK and PI3k/Akt signaling pathways are required for establishing persistent SARS-CoV infection in Vero E6 cells. (edit)
SARS coronavirus (edit) Kinetics and synergistic effects of siRNAs targeting structural and replicase genes of SARS-associated coronavirus. (edit)
SARS coronavirus (edit) Kinetics of severe acute respiratory syndrome (SARS) coronavirus-specific antibodies in 271 laboratory-confirmed cases of SARS (edit)
SARS coronavirus (edit) Label-free, electrical detection of the SARS virus N-protein with nanowire biosensors utilizing antibody mimics as capture probes (edit)
SARS coronavirus (edit) Laboratory containment of SARS virus. (edit)
SARS coronavirus (edit) Lack of association between HLA-A, -B and -DRB1 alleles and the development of SARS: a cohort of 95 SARS-recovered individuals in a population of Guangdong, southern China. (edit)
SARS coronavirus (edit) Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection (edit)
SARS coronavirus (edit) Lack of innate interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret model (edit)
SARS coronavirus (edit) Large-scale preparation of UV-inactivated SARS coronavirus virions for vaccine antigen. (edit)
SARS coronavirus (edit) Lessons learned from SARS outbreak prompt rapid response to new coronavirus. (edit)
SARS coronavirus (edit) Lipid rafts are involved in SARS-CoV entry into Vero E6 cells (edit)
SARS coronavirus (edit) Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients. (edit)
SARS coronavirus (edit) Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. (edit)
SARS coronavirus (edit) Long-term SARS coronavirus excretion from patient cohort, China. (edit)
SARS coronavirus (edit) Long-term persistence of robust antibody and cytotoxic T cell responses in recovered patients infected with SARS coronavirus. (edit)
SARS coronavirus (edit) Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine. (edit)
SARS coronavirus (edit) Longitudinal analysis of Severe Acute Respiratory Syndrome (SARS) coronavirus-specific antibody in SARS patients. (edit)
SARS coronavirus (edit) Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance. (edit)
SARS coronavirus (edit) Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus. (edit)
SARS coronavirus (edit) Longitudinal surveillance of SARS-like coronaviruses in bats by quantitative real-time PCR. (edit)
SARS coronavirus (edit) Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. (edit)
SARS coronavirus (edit) MERS, SARS and other coronaviruses as causes of pneumonia. (edit)
SARS coronavirus (edit) Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses. (edit)
SARS coronavirus (edit) Mapping a neutralizing epitope on the SARS coronavirus spike protein: computational prediction based on affinity-selected peptides. (edit)
SARS coronavirus (edit) Mass spectrometric characterization of proteins from the SARS virus: a preliminary report. (edit)
SARS coronavirus (edit) Mechanism for controlling the monomer-dimer conversion of SARS coronavirus main protease (edit)
SARS coronavirus (edit) Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. (edit)
SARS coronavirus (edit) Medical treatment of viral pneumonia including SARS in immunocompetent adult. (edit)
SARS coronavirus (edit) Medusa's ugly head again: from SARS to MERS-CoV. (edit)
SARS coronavirus (edit) Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection. (edit)
SARS coronavirus (edit) Mice susceptible to SARS coronavirus (edit)
SARS coronavirus (edit) Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection. (edit)
SARS coronavirus (edit) Microarray and real-time RT-PCR analyses of differential human gene expression patterns induced by severe acute respiratory syndrome (SARS) coronavirus infection of Vero cells. (edit)
SARS coronavirus (edit) Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease (edit)
SARS coronavirus (edit) Middle East respiratory syndrome: SARS redux? (edit)
SARS coronavirus (edit) Mining SARS-CoV protease cleavage data using non-orthogonal decision trees: a novel method for decisive template selection. (edit)
SARS coronavirus (edit) Moderate mutation rate in the SARS coronavirus genome and its implications (edit)
SARS coronavirus (edit) Modification of SARS-CoV S1 gene render expression in Pichia pastoris. (edit)
SARS coronavirus (edit) Molecular advances in severe acute respiratory syndrome-associated coronavirus (SARS-CoV). (edit)
SARS coronavirus (edit) Molecular advances in the cell biology of SARS-CoV and current disease prevention strategies (edit)
SARS coronavirus (edit) Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus. (edit)
SARS coronavirus (edit) Molecular cloning, expression, and purification of SARS-CoV nsp13. (edit)
SARS coronavirus (edit) Molecular cloning, expression, purification, and mass spectrometric characterization of 3C-like protease of SARS coronavirus. (edit)
SARS coronavirus (edit) Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV Mpro. (edit)
SARS coronavirus (edit) Molecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV 3CL(pro) inhibitors. (edit)
SARS coronavirus (edit) Molecular epidemiology of SARS-associated coronavirus, Beijing (edit)
SARS coronavirus (edit) Molecular evolution and multilocus sequence typing of 145 strains of SARS-CoV. (edit)
SARS coronavirus (edit) Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. (edit)
SARS coronavirus (edit) Molecular modelling of S1 and S2 subunits of SARS coronavirus spike glycoprotein. (edit)
SARS coronavirus (edit) Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV). (edit)
SARS coronavirus (edit) Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV). (edit)
SARS coronavirus (edit) Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins. (edit)
SARS coronavirus (edit) Morphology and morphogenesis of severe acute respiratory syndrome (SARS)-associated virus. (edit)
SARS coronavirus (edit) Mouse studies of SARS coronavirus-specific immune responses to recombinant replication-defective adenovirus expressing SARS coronavirus N protein. (edit)
SARS coronavirus (edit) Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. (edit)
SARS coronavirus (edit) Multi-organ lesions in suckling mice infected with SARS-associated mammalian reovirus linked with apoptosis induced by viral proteins μ1 and σ1 (edit)
SARS coronavirus (edit) Multi-zone modeling of probable SARS virus transmission by airflow between flats in Block E, Amoy Gardens. (edit)
SARS coronavirus (edit) Murine hepatitis virus strain 1 as a model for severe acute respiratory distress syndrome (SARS). (edit)
SARS coronavirus (edit) Mustela vison ACE2 functions as a receptor for SARS-coronavirus. (edit)
SARS coronavirus (edit) Mutagenesis of the transmembrane domain of the SARS coronavirus spike glycoprotein: refinement of the requirements for SARS coronavirus cell entry. (edit)
SARS coronavirus (edit) Mutation analysis of 20 SARS virus genome sequences: evidence for negative selection in replicase ORF1b and spike gene. (edit)
SARS coronavirus (edit) Mutational and inhibitive analysis of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer-based assays. (edit)
SARS coronavirus (edit) Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003 (edit)
SARS coronavirus (edit) Mutational patterns correlate with genome organization in SARS and other coronaviruses. (edit)
SARS coronavirus (edit) MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV. (edit)
SARS coronavirus (edit) NMR assignment of the protein nsp3a from SARS-CoV. (edit)
SARS coronavirus (edit) Neutralizing antibody against severe acute respiratory syndrome (SARS)-coronavirus spike is highly effective for the protection of mice in the murine SARS model. (edit)
SARS coronavirus (edit) Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein. (edit)
SARS coronavirus (edit) Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology (edit)
SARS coronavirus (edit) New Frameshifting Pseudoknot Found in SARS Virus (edit)
SARS coronavirus (edit) New Potent SARS-CoV 3C-Like Protease Inhibitors Derived from Thieno[2,3-d]-pyrimidine Derivatives. (edit)
SARS coronavirus (edit) New antiviral drugs, vaccines and classic public health interventions against SARS coronavirus. (edit)
SARS coronavirus (edit) New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CL(pro) inhibitors. (edit)
SARS coronavirus (edit) Novel Alphacoronaviruses and Paramyxoviruses Cocirculate with Type 1 and Severe Acute Respiratory System (SARS)-Related Betacoronaviruses in Synanthropic Bats of Luxembourg. (edit)
SARS coronavirus (edit) Novel SARS-like betacoronaviruses in bats, China, 2011. (edit)
SARS coronavirus (edit) Novel rapid immunochromatographic test based on an enzyme immunoassay for detecting nucleocapsid antigen in SARS-associated coronavirus. (edit)
SARS coronavirus (edit) Novel system for detecting SARS coronavirus nucleocapsid protein using an ssDNA aptamer. (edit)
SARS coronavirus (edit) Object-oriented biological system integration: a SARS coronavirus example. (edit)
SARS coronavirus (edit) Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs. (edit)
SARS coronavirus (edit) One-tube nested RT-PCR enabled by using a plastic film and its application for the rapid detection of SARS-virus. (edit)
SARS coronavirus (edit) Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate. (edit)
SARS coronavirus (edit) Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. (edit)
SARS coronavirus (edit) Osteonecrosis in patients after severe acute respiratory syndrome (SARS): possible role of anticardiolipin antibodies. (edit)
SARS coronavirus (edit) PIKA provides an adjuvant effect to induce strong mucosal and systemic humoral immunity against SARS-CoV. (edit)
SARS coronavirus (edit) Palindromes in SARS and Other Coronaviruses (edit)
SARS coronavirus (edit) Palmitoylation of SARS-CoV S protein is necessary for partitioning into detergent-resistant membranes and cell-cell fusion but not interaction with M protein. (edit)
SARS coronavirus (edit) Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion. (edit)
SARS coronavirus (edit) Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition. (edit)
SARS coronavirus (edit) Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus. (edit)
SARS coronavirus (edit) Pathogenesis of SARS coronavirus infection using human lung epithelial cells: an in vitro model. (edit)
SARS coronavirus (edit) Pathological Clues to How the SARS Virus Kills (edit)
SARS coronavirus (edit) Pathology of experimental SARS coronavirus infection in cats and ferrets. (edit)
SARS coronavirus (edit) Pathology of guinea pigs experimentally infected with a novel reovirus and coronavirus isolated from SARS patients. (edit)
SARS coronavirus (edit) Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. (edit)
SARS coronavirus (edit) Peptide domain involved in the interaction between membrane protein and nucleocapsid protein of SARS-associated coronavirus. (edit)
SARS coronavirus (edit) Peptide mimicrying between SARS coronavirus spike protein and human proteins reacts with SARS patient serum. (edit)
SARS coronavirus (edit) Peptides derived from HIV-1, HIV-2, Ebola virus, SARS coronavirus and coronavirus 229E exhibit high affinity binding to the formyl peptide receptor. (edit)
SARS coronavirus (edit) Peptides from the SARS-associated coronavirus as tags for protein expression and purification. (edit)
SARS coronavirus (edit) Persistent infection of SARS coronavirus in colonic cells in vitro. (edit)
SARS coronavirus (edit) Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen (edit)
SARS coronavirus (edit) Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase. (edit)
SARS coronavirus (edit) Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus. (edit)
SARS coronavirus (edit) Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells. (edit)
SARS coronavirus (edit) Phylogenetic analysis and sequence comparisons of structural and non-structural SARS coronavirus proteins in Taiwan. (edit)
SARS coronavirus (edit) Phylogenetic analysis of the full-length SARS-CoV sequences: evidence for phylogenetic discordance in three genomic regions. (edit)
SARS coronavirus (edit) Phylogenetic perspectives on the epidemiology and origins of SARS and SARS-like coronaviruses. (edit)
SARS coronavirus (edit) Phylogenomics and bioinformatics of SARS-CoV. (edit)
SARS coronavirus (edit) Phylogeny of the SARS coronavirus. (edit)
SARS coronavirus (edit) Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells. (edit)
SARS coronavirus (edit) Piezoelectric immunosensor for SARS-associated coronavirus in sputum. (edit)
SARS coronavirus (edit) Polymorphism of SARS-CoV genomes. (edit)
SARS coronavirus (edit) Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide. (edit)
SARS coronavirus (edit) Possible SARS coronavirus transmission during cardiopulmonary resuscitation (edit)
SARS coronavirus (edit) Possible central nervous system infection by SARS coronavirus (edit)
SARS coronavirus (edit) Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients. (edit)
SARS coronavirus (edit) Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid. (edit)
SARS coronavirus (edit) Potent and specific inhibition of SARS-CoV antigen expression by RNA interference. (edit)
SARS coronavirus (edit) Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies. (edit)
SARS coronavirus (edit) Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus. (edit)
SARS coronavirus (edit) Potent inhibition of SARS-associated coronavirus (SCOV) infection and replication by type I interferons (IFN-alpha/beta) but not by type II interferon (IFN-gamma). (edit)
SARS coronavirus (edit) Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. (edit)
SARS coronavirus (edit) Potential antivirals and antiviral strategies against SARS coronavirus infections. (edit)
SARS coronavirus (edit) Potential cross-reactivity of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid (N)-based IgG ELISA assay for plasma samples from HIV-1 positive intravenous drug users (IDUs). (edit)
SARS coronavirus (edit) Potential for receptor-based antiviral drugs against SARS. (edit)
SARS coronavirus (edit) Potential targets for anti-SARS drugs in the structural proteins from SARS related coronavirus. (edit)
SARS coronavirus (edit) Prediction of amino acid pairs sensitive to mutations in the spike protein from SARS related coronavirus. (edit)
SARS coronavirus (edit) Prediction of functional class of the SARS coronavirus proteins by a statistical learning method. (edit)
SARS coronavirus (edit) Prediction of proteinase cleavage sites in polyproteins of coronaviruses and its applications in analyzing SARS-CoV genomes. (edit)
SARS coronavirus (edit) Prediction of quaternary assembly of SARS coronavirus peplomer. (edit)
SARS coronavirus (edit) Preliminary study on the detection of the SARS-CoV specific target cDNA fragments by multiplex PCR. (edit)
SARS coronavirus (edit) Preparation and characterization of monoclonal antibodies against S1 domain at N-terminal residues 249 to 667 of SARS-associated coronavirus S1 protein. (edit)
SARS coronavirus (edit) Preparation and evaluation of anti-SARS coronavirus IgY from yolks of immunized SPF chickens. (edit)
SARS coronavirus (edit) Prevalence of IgG antibody to SARS-associated coronavirus in animal traders--Guangdong Province, China, 2003. (edit)
SARS coronavirus (edit) Prevalence of SARS-CoV antibody in all Hong Kong patient contacts. (edit)
SARS coronavirus (edit) Prevalence of non-pneumonic infections with SARS-correlated virus. (edit)
SARS coronavirus (edit) Prevalence of non-pneumonic infections with SARS-correlated virus. (edit)
SARS coronavirus (edit) Prevalence of subclinical infection by the SARS coronavirus among general practitioners in Hong Kong. (edit)
SARS coronavirus (edit) Primary characterization of SARS coronavirus strain Frankfurt 1. (edit)
SARS coronavirus (edit) Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection. (edit)
SARS coronavirus (edit) Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV. (edit)
SARS coronavirus (edit) Probing the structure of the SARS coronavirus using scanning electron microscopy. (edit)
SARS coronavirus (edit) Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection. (edit)
SARS coronavirus (edit) Production of a monoclonal antibody against SARS-CoV spike protein with single intrasplenic immunization of plasmid DNA. (edit)
SARS coronavirus (edit) Production of an anti-severe acute respiratory syndrome (SARS) coronavirus human monoclonal antibody Fab fragment by using a combinatorial immunoglobulin gene library derived from patients who recovered from SARS. (edit)
SARS coronavirus (edit) Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43. (edit)
SARS coronavirus (edit) Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients. (edit)
SARS coronavirus (edit) Profile of specific antibodies to the SARS-associated coronavirus. (edit)
SARS coronavirus (edit) Profiles of IgG antibodies to nucleocapsid and spike proteins of the SARS-associated coronavirus in SARS patients. (edit)
SARS coronavirus (edit) Programmed ribosomal frameshifting in HIV-1 and the SARS-CoV. (edit)
SARS coronavirus (edit) Programmed ribosomal frameshifting in decoding the SARS-CoV genome (edit)
SARS coronavirus (edit) Progress in Anti-SARS Coronavirus Chemistry, Biology and Chemotherapy. (edit)
SARS coronavirus (edit) Prokaryotic expression, refolding, and purification of fragment 450-650 of the spike protein of SARS-coronavirus. (edit)
SARS coronavirus (edit) Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids. (edit)
SARS coronavirus (edit) Promoter activity of SARS coronavirus 5' UTR sequence in eukaryotic cells. (edit)
SARS coronavirus (edit) Properties of isonucleotide-incorporated oligodeoxynucleotides and inhibition of the expression of spike protein of SARS-CoV. (edit)
SARS coronavirus (edit) Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus. (edit)
SARS coronavirus (edit) Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol® (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model. (edit)
SARS coronavirus (edit) Proposal for vaccination against SARS coronavirus using avian infectious bronchitis virus strain H from The Netherlands. (edit)
SARS coronavirus (edit) Protein transfer enhances cellular immune responses to DNA vaccination against SARS-CoV. (edit)
SARS coronavirus (edit) Proteomic analysis of SARS associated coronavirus using two-dimensional liquid chromatography mass spectrometry and one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by mass spectroemtric analysis. (edit)
SARS coronavirus (edit) Pseudotyped vesicular stomatitis virus for analysis of virus entry mediated by SARS coronavirus spike proteins. (edit)
SARS coronavirus (edit) Pseudotyped vesicular stomatitis virus for functional analysis of SARS coronavirus spike protein. (edit)
SARS coronavirus (edit) Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS). (edit)
SARS coronavirus (edit) Putative hAPN receptor binding sites in SARS_CoV spike protein. (edit)
SARS coronavirus (edit) Pyridine N-oxide derivatives are inhibitory to the human SARS and feline infectious peritonitis coronavirus in cell culture. (edit)
SARS coronavirus (edit) Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome. (edit)
SARS coronavirus (edit) Quantitative analysis of severe acute respiratory syndrome (SARS)-associated coronavirus-infected cells using proteomic approaches: implications for cellular responses to virus infection. (edit)
SARS coronavirus (edit) Quantitative and sensitive detection of the SARS-CoV spike protein using bispecific monoclonal antibody-based enzyme-linked immunoassay. (edit)
SARS coronavirus (edit) Quantitative comparison of the efficiency of antibodies against S1 and S2 subunit of SARS coronavirus spike protein in virus neutralization and blocking of receptor binding: implications for the functional roles of S2 subunit. (edit)
SARS coronavirus (edit) Quantitative evaluation of infection control models in the prevention of nosocomial transmission of SARS virus to healthcare workers: implication to nosocomial viral infection control for healthcare workers. (edit)
SARS coronavirus (edit) Quantitative temporal-spatial distribution of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) in post-mortem tissues. (edit)
SARS coronavirus (edit) Questions about comparative genomics of SARS coronavirus isolates. (edit)
SARS coronavirus (edit) RNA aptamer-based sensitive detection of SARS coronavirus nucleocapsid protein. (edit)
SARS coronavirus (edit) RNA dimerization plays a role in ribosomal frameshifting of the SARS coronavirus. (edit)
SARS coronavirus (edit) Rapid and sensitive detection of multiple genes from the SARS-coronavirus using quantitative RT-PCR with dual systems. (edit)
SARS coronavirus (edit) Rapid detection of the severe acute respiratory syndrome (SARS) coronavirus by a loop-mediated isothermal amplification assay. (edit)
SARS coronavirus (edit) Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (SARS). (edit)
SARS coronavirus (edit) Rapid peptide-based screening on the substrate specificity of severe acute respiratory syndrome (SARS) coronavirus 3C-like protease by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. (edit)
SARS coronavirus (edit) Real-time NASBA detection of SARS-associated coronavirus and comparison with real-time reverse transcription-PCR (edit)
SARS coronavirus (edit) Real-time polymerase chain reaction for detecting SARS coronavirus, Beijing, 2003 (edit)
SARS coronavirus (edit) Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus. (edit)
SARS coronavirus (edit) Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. (edit)
SARS coronavirus (edit) Receptor recognition and cross-species infections of SARS coronavirus (edit)
SARS coronavirus (edit) Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. (edit)
SARS coronavirus (edit) Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines. (edit)
SARS coronavirus (edit) Recombinant protein-based enzyme-linked immunosorbent assay and immunochromatographic tests for detection of immunoglobulin G antibodies to severe acute respiratory syndrome (SARS) coronavirus in SARS patients. (edit)
SARS coronavirus (edit) Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity. (edit)
SARS coronavirus (edit) Reconstitution of the receptor-binding motif of the SARS coronavirus. (edit)
SARS coronavirus (edit) Recurrent mutations associated with isolation and passage of SARS coronavirus in cells from non-human primates. (edit)
SARS coronavirus (edit) Reduced incorporation of SARS-CoV spike protein into viral particles due to amino acid substitutions within the receptor binding domain. (edit)
SARS coronavirus (edit) Reference gene selection for quantitative real-time PCR analysis in virus infected cells: SARS corona virus, Yellow fever virus, Human Herpesvirus-6, Camelpox virus and Cytomegalovirus infections (edit)
SARS coronavirus (edit) Regulation of p90RSK phosphorylation by SARS-CoV infection in Vero E6 cells. (edit)
SARS coronavirus (edit) Relationship of SARS-CoV to other pathogenic RNA viruses explored by tetranucleotide usage profiling (edit)
SARS coronavirus (edit) Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. (edit)
SARS coronavirus (edit) Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys. (edit)
SARS coronavirus (edit) Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506. (edit)
SARS coronavirus (edit) Residue analysis of a CTL epitope of SARS-CoV spike protein by IFN-gamma production and bioinformatics prediction. (edit)
SARS coronavirus (edit) Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals. (edit)
SARS coronavirus (edit) Reverse genetics of SARS-related coronavirus using vaccinia virus-based recombination. (edit)
SARS coronavirus (edit) Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines. (edit)
SARS coronavirus (edit) Ribavirin for SARS in children. (edit)
SARS coronavirus (edit) Ribavirin in the treatment of SARS: A new trick for an old drug? (edit)
SARS coronavirus (edit) Ribavirin in the treatment of severe acute respiratory syndrome (SARS). (edit)
SARS coronavirus (edit) Risks to healthcare workers with emerging diseases: lessons from MERS-CoV, Ebola, SARS, and avian flu. (edit)
SARS coronavirus (edit) Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. (edit)
SARS coronavirus (edit) Roles of spike protein in the pathogenesis of SARS coronavirus. (edit)
SARS coronavirus (edit) Routes of transmission of influenza A H1N1, SARS CoV, and norovirus in air cabin: Comparative analyses. (edit)
SARS coronavirus (edit) SARS CoV replication and pathogenesis in human airway epithelial cultures. (edit)
SARS coronavirus (edit) SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement. (edit)
SARS coronavirus (edit) SARS Coronavirus Fusion Peptide-Derived Sequence Suppresses Collagen-Induced Arthritis in DBA/1J Mice. (edit)
SARS coronavirus (edit) SARS Coronaviruses and Highly Pathogenic Influenza Viruses: Safety and Occupational Health for Laboratory Workers. (edit)
SARS coronavirus (edit) SARS and MERS: recent insights into emerging coronaviruses. (edit)
SARS coronavirus (edit) SARS and common viral infections. (edit)
SARS coronavirus (edit) SARS and other coronaviruses in humans and animals. (edit)
SARS coronavirus (edit) SARS associated coronavirus has a recombinant polymerase and coronaviruses have a history of host-shifting. (edit)
SARS coronavirus (edit) SARS corona virus peptides recognized by antibodies in the sera of convalescent cases. (edit)
SARS coronavirus (edit) SARS coronavirus 8b reduces viral replication by down-regulating E via an ubiquitin-independent proteasome pathway. (edit)
SARS coronavirus (edit) SARS coronavirus and apoptosis. (edit)
SARS coronavirus (edit) SARS coronavirus and innate immunity. (edit)
SARS coronavirus (edit) SARS coronavirus anti-infectives. (edit)
SARS coronavirus (edit) SARS coronavirus detection methods. (edit)
SARS coronavirus (edit) SARS coronavirus detection. (edit)
SARS coronavirus (edit) SARS coronavirus induces apoptosis in Vero E6 cells. (edit)
SARS coronavirus (edit) SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens. (edit)
SARS coronavirus (edit) SARS coronavirus nucleocapsid protein monoclonal antibodies developed using a prokaryotic expressed protein. (edit)
SARS coronavirus (edit) SARS coronavirus papain-like protease induces Egr-1-dependent up-regulation of TGF-β1 via ROS/p38 MAPK/STAT3 pathway. (edit)
SARS coronavirus (edit) SARS coronavirus papain-like protease up-regulates the collagen expression through non-Samd TGF-β1 signaling. (edit)
SARS coronavirus (edit) SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon. (edit)
SARS coronavirus (edit) SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus. (edit)
SARS coronavirus (edit) SARS coronavirus without reservoir originated from an unnatural evolution, experienced the reverse evolution, and finally disappeared in the world. (edit)
SARS coronavirus (edit) SARS coronavirus: a new challenge for prevention and therapy. (edit)
SARS coronavirus (edit) SARS diagnosis, monitoring and prognostication by SARS-coronavirus RNA detection. (edit)
SARS coronavirus (edit) SARS genome chip available to scientists: the NIAID hopes that widespread access to the SARS genome chip will catalyse research into effective treatments for the virus. (edit)
SARS coronavirus (edit) SARS patients-derived human recombinant antibodies to S and M proteins efficiently neutralize SARS-coronavirus infectivity. (edit)
SARS coronavirus (edit) SARS transmission pattern in Singapore reassessed by viral sequence variation analysis (edit)
SARS coronavirus (edit) SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector. (edit)
SARS coronavirus (edit) SARS veterans tackle coronavirus. (edit)
SARS coronavirus (edit) SARS viral RNA. (edit)
SARS coronavirus (edit) SARS virus identified, but the disease is still spreading. (edit)
SARS coronavirus (edit) SARS virus in tears? (edit)
SARS coronavirus (edit) SARS virus returns to China as scientists race to find effective vaccine. (edit)
SARS coronavirus (edit) SARS virus: the beginning of the unraveling of a new coronavirus. (edit)
SARS coronavirus (edit) SARS--beginning to understand a new virus. (edit)
SARS coronavirus (edit) SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii. (edit)
SARS coronavirus (edit) SARS-CoV ORF1b-encoded nonstructural proteins 12-16: replicative enzymes as antiviral targets. (edit)
SARS coronavirus (edit) SARS-CoV and IFN: Too Little, Too Late. (edit)
SARS coronavirus (edit) SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission. (edit)
SARS coronavirus (edit) SARS-CoV antibody prevalence in all Hong Kong patient contacts (edit)
SARS coronavirus (edit) SARS-CoV genome polymorphism: a bioinformatics study (edit)
SARS coronavirus (edit) SARS-CoV heptad repeat 2 is a trimer of parallel helices. (edit)
SARS coronavirus (edit) SARS-CoV infection in a restaurant from palm civet. (edit)
SARS coronavirus (edit) SARS-CoV infection was from at least two origins in the Taiwan area. (edit)
SARS coronavirus (edit) SARS-CoV nucleocapsid protein induced apoptosis of COS-1 mediated by the mitochondrial pathway. (edit)
SARS coronavirus (edit) SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism. (edit)
SARS coronavirus (edit) SARS-CoV protease inhibitors design using virtual screening method from natural products libraries. (edit)
SARS coronavirus (edit) SARS-CoV regulates immune function-related gene expression in human monocytic cells. (edit)
SARS coronavirus (edit) SARS-CoV related Betacoronavirus and diverse Alphacoronavirus members found in western old-world. (edit)
SARS coronavirus (edit) SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells. (edit)
SARS coronavirus (edit) SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium (edit)
SARS coronavirus (edit) SARS-CoV sampling from 3 portals. (edit)
SARS coronavirus (edit) SARS-CoV spike protein-expressing recombinant vaccinia virus efficiently induces neutralizing antibodies in rabbits pre-immunized with vaccinia virus. (edit)
SARS coronavirus (edit) SARS-CoV spike proteins expressed by the vaccinia virus Tiantan strain: secreted sq protein induces robust neutralization antibody in mice. (edit)
SARS coronavirus (edit) SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues. (edit)
SARS coronavirus (edit) SARS-CoV, but not HCoV-NL63, utilizes cathepsins to infect cells: viral entry. (edit)
SARS coronavirus (edit) SARS-CoV-Encoded Small RNAs Contribute to Infection-Associated Lung Pathology. (edit)
SARS coronavirus (edit) SARS-CoV: Lessons for global health (edit)
SARS coronavirus (edit) SARS-Coronavirus ancestor's foot-prints in South-East Asian bat colonies and the refuge theory. (edit)
SARS coronavirus (edit) SARS-associated coronavirus infection in teenagers. (edit)
SARS coronavirus (edit) SARS-associated coronavirus quasispecies in individual patients. (edit)
SARS coronavirus (edit) SARS-associated coronavirus replication in cell lines. (edit)
SARS coronavirus (edit) SARS-associated coronavirus transmission, United States (edit)
SARS coronavirus (edit) SARS-associated coronavirus transmitted from human to pig (edit)
SARS coronavirus (edit) SARS-associated coronavirus. (edit)
SARS coronavirus (edit) SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. (edit)
SARS coronavirus (edit) SARS-coronavirus (SARS-CoV) and the safety of a solvent/detergent (S/D) treated immunoglobulin preparation. (edit)
SARS coronavirus (edit) SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. (edit)
SARS coronavirus (edit) SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients. (edit)
SARS coronavirus (edit) SARS-coronavirus replication in human peripheral monocytes/macrophages. (edit)
SARS coronavirus (edit) SARS-coronavirus replication/transcription complexes are membrane-protected and need a host factor for activity in vitro (edit)
SARS coronavirus (edit) SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion. (edit)
SARS coronavirus (edit) SARS-like virus in the Middle East: a truly bat-related coronavirus causing human diseases (edit)
SARS coronavirus (edit) SARS-like virus reignites ownership feuds. (edit)
SARS coronavirus (edit) SARS-related virus predating SARS outbreak, Hong Kong (edit)
SARS coronavirus (edit) SARS-unique fold in the Rousettus bat coronavirus HKU9. (edit)
SARS coronavirus (edit) SARS: an amalgam of avian and mammalian viruses? (edit)
SARS coronavirus (edit) SARS: clinical virology and pathogenesis. (edit)
SARS coronavirus (edit) SARS: just another viral acronym? (edit)
SARS coronavirus (edit) SARS: lessons learned from other coronaviruses. (edit)
SARS coronavirus (edit) SARS: responding to an unknown virus. (edit)
SARS coronavirus (edit) SARS: understanding the coronavirus: accuracy of WHO criteria was similar in a "non-SARS" hospital in Singapore. (edit)
SARS coronavirus (edit) SARS: understanding the coronavirus: apoptosis may explain lymphopenia of SARS. (edit)
SARS coronavirus (edit) SARS: understanding the virus and development of rational therapy. (edit)
SARS coronavirus (edit) Screening and identification of linear B-cell epitopes and entry-blocking peptide of severe acute respiratory syndrome (SARS)-associated coronavirus using synthetic overlapping peptide library. (edit)
SARS coronavirus (edit) Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease. (edit)
SARS coronavirus (edit) Screening of electrophilic compounds yields an aziridinyl peptide as new active-site directed SARS-CoV main protease inhibitor. (edit)
SARS coronavirus (edit) Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals. (edit)
SARS coronavirus (edit) Selection of SARS-coronavirus-specific B cell epitopes by phage peptide library screening and evaluation of the immunological effect of epitope-based peptides on mice. (edit)
SARS coronavirus (edit) Self-assembly of a nine-residue amyloid-forming peptide fragment of SARS corona virus E-protein: mechanism of self aggregation and amyloid-inhibition of hIAPP. (edit)
SARS coronavirus (edit) Sensitive detection of SARS coronavirus RNA by a novel asymmetric multiplex nested RT-PCR amplification coupled with oligonucleotide microarray hybridization. (edit)
SARS coronavirus (edit) Sensitivity of SARS/MERS CoV to interferons and other drugs based on achievable serum concentrations in humans. (edit)
SARS coronavirus (edit) Sequential affinity purification of peroxidase tagged bispecific anti-SARS-CoV antibodies on phenylboronic acid agarose (edit)
SARS coronavirus (edit) Serial analysis of the plasma concentration of SARS coronavirus RNA in pediatric patients with severe acute respiratory syndrome. (edit)
SARS coronavirus (edit) Seroepidemiological Study on SARS-CoV IgG Antibodies of Different Populations from Several Areas (edit)
SARS coronavirus (edit) Serologic and molecular biologic methods for SARS-associated coronavirus infection, Taiwan. (edit)
SARS coronavirus (edit) Serological Evidence of Bat SARS-Related Coronavirus Infection in Humans, China. (edit)
SARS coronavirus (edit) Seroprevalence of SARS Coronavirus Among Residents Near a Hospital with a Nosocomial Outbreak. (edit)
SARS coronavirus (edit) Seroprevalence of SARS coronavirus antibody in household contacts. (edit)
SARS coronavirus (edit) Seroprevalence of antibody to severe acute respiratory syndrome (SARS)-associated coronavirus among health care workers in SARS and non-SARS medical wards. (edit)
SARS coronavirus (edit) Severe Acute Respiratory Syndrome (SARS) Coronavirus ORF8 Protein Is Acquired from SARS-Related Coronavirus from Greater Horseshoe Bats through Recombination (edit)
SARS coronavirus (edit) Severe Acute Respiratory Syndrome (SARS) and the GDP. Part I : Epidemiology, virology, pathology and general health issues. (edit)
SARS coronavirus (edit) Severe acute respiratory syndrome (SARS) and coronavirus testing--United States, 2003. (edit)
SARS coronavirus (edit) Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells (edit)
SARS coronavirus (edit) Severe acute respiratory syndrome (SARS) coronavirus. (edit)
SARS coronavirus (edit) Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine. (edit)
SARS coronavirus (edit) Severe acute respiratory syndrome (SARS) coronavirus: possible re-emergence of the Asian-global novel threat. (edit)
SARS coronavirus (edit) Severe acute respiratory syndrome (SARS)--paradigm of an emerging viral infection. (edit)
SARS coronavirus (edit) Severe acute respiratory syndrome (SARS): an old virus jumping into a new host or a new creation? (edit)
SARS coronavirus (edit) Severe acute respiratory syndrome (SARS): development of diagnostics and antivirals. (edit)
SARS coronavirus (edit) Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. (edit)
SARS coronavirus (edit) Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group (edit)
SARS coronavirus (edit) Signal transduction in SARS-CoV-infected cells. (edit)
SARS coronavirus (edit) Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference. (edit)
SARS coronavirus (edit) Silencing of SARS-CoV spike gene by small interfering RNA in HEK 293T cells. (edit)
SARS coronavirus (edit) Simultaneous detection of SARS coronavirus and influenza A viruses using real-time polymerase chain reaction. (edit)
SARS coronavirus (edit) Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model (edit)
SARS coronavirus (edit) Small interfering RNA effectively inhibits the expression of SARS coronavirus membrane gene at two novel targeting sites. (edit)
SARS coronavirus (edit) Small interfering RNA inhibits SARS-CoV nucleocapsid gene expression in cultured cells and mouse muscles. (edit)
SARS coronavirus (edit) Solution structure of the X4 protein coded by the SARS related coronavirus reveals an immunoglobulin like fold and suggests a binding activity to integrin I domains. (edit)
SARS coronavirus (edit) Stability and inactivation of SARS coronavirus. (edit)
SARS coronavirus (edit) Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. (edit)
SARS coronavirus (edit) Stem-loop 1 in the 5' UTR of the SARS coronavirus can substitute for its counterpart in mouse hepatitis virus. (edit)
SARS coronavirus (edit) Structural analysis of inhibition mechanisms of aurintricarboxylic acid on SARS-CoV polymerase and other proteins. (edit)
SARS coronavirus (edit) Structural and biochemical basis for the difference in the helicase activity of two different constructs of SARS-CoV helicase. (edit)
SARS coronavirus (edit) Structural and biochemical investigation of heptad repeat derived peptides of human SARS corona virus (hSARS-CoV) spike protein. (edit)
SARS coronavirus (edit) Structural and dynamic characterization of the interaction of the putative fusion peptide of the S2 SARS-CoV virus protein with lipid membranes. (edit)
SARS coronavirus (edit) Structural biology. Adaptation of SARS coronavirus to humans. (edit)
SARS coronavirus (edit) Structural insights into SARS coronavirus proteins. (edit)
SARS coronavirus (edit) Structural insights of a self-assembling 9-residue peptide from the C-terminal tail of the SARS corona virus E-protein in DPC and SDS micelles: A combined high and low resolution spectroscopic study. (edit)
SARS coronavirus (edit) Structural organization of the genome of SARS-associated coronavirus (Strain SoD) isolated on the territory of the Russian Federation. (edit)
SARS coronavirus (edit) Structural proteomics of the SARS coronavirus: a model response to emerging infectious diseases. (edit)
SARS coronavirus (edit) Structure based computational assessment of channel properties of assembled ORF-8a from SARS-CoV. (edit)
SARS coronavirus (edit) Structure of a Conserved RNA Element in the SARS Virus Genome Determined (edit)
SARS coronavirus (edit) Structure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501 (edit)
SARS coronavirus (edit) Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors (edit)
SARS coronavirus (edit) Structure-based preliminary analysis of immunity and virulence of SARS coronavirus. (edit)
SARS coronavirus (edit) Structure-based virtual screening against SARS-3CL(pro) to identify novel non-peptidic hits. (edit)
SARS coronavirus (edit) Studies explore impact of new pathogens: investigators report on metapneumovirus, SARS. (edit)
SARS coronavirus (edit) Studies of SARS virus vaccines. (edit)
SARS coronavirus (edit) Study on interaction between SARS-CoV N and MAP19 (edit)
SARS coronavirus (edit) Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain. (edit)
SARS coronavirus (edit) Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibody (edit)
SARS coronavirus (edit) Substrate specificity and rational design of peptidomimetic inhibitors for SARS coronavirus main protease. (edit)
SARS coronavirus (edit) Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus (edit)
SARS coronavirus (edit) Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein. (edit)
SARS coronavirus (edit) Surface ultrastructure of SARS coronavirus revealed by atomic force microscopy. (edit)
SARS coronavirus (edit) Surface vimentin is critical for the cell entry of SARS-CoV. (edit)
SARS coronavirus (edit) Susceptibility of different eukaryotic cell lines to SARS-coronavirus. (edit)
SARS coronavirus (edit) Susceptibility of human and rat neural cell lines to infection by SARS-coronavirus. (edit)
SARS coronavirus (edit) Susceptibility of pigs and chickens to SARS coronavirus (edit)
SARS coronavirus (edit) Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor. (edit)
SARS coronavirus (edit) Symptoms of infection caused by SARS coronavirus in laboratory mice and guinea pigs. (edit)
SARS coronavirus (edit) Synergistic inhibition of SARS-coronavirus replication by type I and type II IFN. (edit)
SARS coronavirus (edit) Synergistic inhibitor binding to the papain-like protease of human SARS coronavirus: mechanistic and inhibitor design implications. (edit)
SARS coronavirus (edit) Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase. (edit)
SARS coronavirus (edit) Synthesis and antiviral evaluation of 7-O-arylmethylquercetin derivatives against SARS-associated coronavirus (SCV) and hepatitis C virus (HCV). (edit)
SARS coronavirus (edit) Synthesis and biological evaluation of nucleoside analogues having 6-chloropurine as anti-SARS-CoV agents. (edit)
SARS coronavirus (edit) Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors. (edit)
SARS coronavirus (edit) Synthesis and evaluation of phenylisoserine derivatives for the SARS-CoV 3CL protease inhibitor. (edit)
SARS coronavirus (edit) Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors. (edit)
SARS coronavirus (edit) Synthesis of cyclopentenyl carbocyclic nucleosides as potential antiviral agents against orthopoxviruses and SARS. (edit)
SARS coronavirus (edit) Synthesis of novel test compounds for antiviral chemotherapy of severe acute respiratory syndrome (SARS). (edit)
SARS coronavirus (edit) Synthesis of stilbene derivatives with inhibition of SARS coronavirus replication. (edit)
SARS coronavirus (edit) Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor. (edit)
SARS coronavirus (edit) Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease. (edit)
SARS coronavirus (edit) Synthesis, modification and docking studies of 5-sulfonyl isatin derivatives as SARS-CoV 3C-like protease inhibitors. (edit)
SARS coronavirus (edit) Synthetic peptide studies on the severe acute respiratory syndrome (SARS) coronavirus spike glycoprotein: perspective for SARS vaccine development. (edit)
SARS coronavirus (edit) Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice. (edit)
SARS coronavirus (edit) Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential. (edit)
SARS coronavirus (edit) Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus. (edit)
SARS coronavirus (edit) Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice. (edit)
SARS coronavirus (edit) T cell responses to whole SARS coronavirus in humans. (edit)
SARS coronavirus (edit) T-Cell response profiling to biological threat agents including the SARS coronavirus. (edit)
SARS coronavirus (edit) T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS. (edit)
SARS coronavirus (edit) T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV. (edit)
SARS coronavirus (edit) TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds. (edit)
SARS coronavirus (edit) TNF-alpha inhibition for potential therapeutic modulation of SARS coronavirus infection. (edit)
SARS coronavirus (edit) Tears and conjunctival scrapings for coronavirus in patients with SARS. (edit)
SARS coronavirus (edit) Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus. (edit)
SARS coronavirus (edit) Ten years after SARS: where was the virus from? (edit)
SARS coronavirus (edit) Tertiary structure prediction of SARS coronavirus helicase. (edit)
SARS coronavirus (edit) Testing the hypothesis of a recombinant origin of the SARS-associated coronavirus. (edit)
SARS coronavirus (edit) The C-terminal portion of the nucleocapsid protein demonstrates SARS-CoV antigenicity. (edit)
SARS coronavirus (edit) The Effects of Temperature and Relative Humidity on the Viability of the SARS Coronavirus. (edit)
SARS coronavirus (edit) The H7N9 influenza virus in China--changes since SARS. (edit)
SARS coronavirus (edit) The R protein of SARS-CoV: analyses of structure and function based on four complete genome sequences of isolates BJ01-BJ04 (edit)
SARS coronavirus (edit) The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis. (edit)
SARS coronavirus (edit) The SARS coronavirus E protein interacts with the PALS1 and alters tight junction formation and epithelial morphogenesis. (edit)
SARS coronavirus (edit) The SARS coronavirus nucleocapsid protein--forms and functions. (edit)
SARS coronavirus (edit) The SARS coronavirus: rapid diagnostics in the limelight. (edit)
SARS coronavirus (edit) The SARS-CoV ferret model in an infection-challenge study. (edit)
SARS coronavirus (edit) The SARS-CoV heptad repeat 2 exhibits pH-induced helix formation. (edit)
SARS coronavirus (edit) The SARS-like coronaviruses: the role of bats and evolutionary relationships with SARS coronavirus. (edit)
SARS coronavirus (edit) The SR-rich motif in SARS-CoV nucleocapsid protein is important for virus replication. (edit)
SARS coronavirus (edit) The Severe Acute Respiratory Syndrome (SARS)-coronavirus 3a protein may function as a modulator of the trafficking properties of the spike protein (edit)
SARS coronavirus (edit) The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus. (edit)
SARS coronavirus (edit) The antiviral action of common household disinfectants and antiseptics against murine hepatitis virus, a potential surrogate for SARS coronavirus. (edit)
SARS coronavirus (edit) The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein. (edit)
SARS coronavirus (edit) The design and application of DNA chips for early detection of SARS-CoV from clinical samples. (edit)
SARS coronavirus (edit) The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice. (edit)
SARS coronavirus (edit) The dimer interface of the SARS coronavirus nucleocapsid protein adapts a porcine respiratory and reproductive syndrome virus-like structure. (edit)
SARS coronavirus (edit) The effect of SARS coronavirus on blood system: its clinical findings and the pathophysiologic hypothesis. (edit)
SARS coronavirus (edit) The effect of inhibition of PP1 and TNFα signaling on pathogenesis of SARS coronavirus (edit)
SARS coronavirus (edit) The epitope study on the SARS-CoV nucleocapsid protein. (edit)
SARS coronavirus (edit) The expression of SARS-CoV M gene in P. Pastoris and the diagnostic utility of the expression product. (edit)
SARS coronavirus (edit) The expression of membrane protein augments the specific responses induced by SARS-CoV nucleocapsid DNA immunization. (edit)
SARS coronavirus (edit) The financial impact of controlling a respiratory virus outbreak in a teaching hospital: lessons learned from SARS. (edit)
SARS coronavirus (edit) The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8⁺ T cells are augmented in varying degrees by CpG ODN, PolyI:C and R848. (edit)
SARS coronavirus (edit) The immunity induced by recombinant spike proteins of SARS coronavirus in Balb/c mice. (edit)
SARS coronavirus (edit) The interaction of the SARS coronavirus non-structural protein 10 with the cellular oxido-reductase system causes an extensive cytopathic effect. (edit)
SARS coronavirus (edit) The large 386-nt deletion in SARS-associated coronavirus: evidence for quasispecies? (edit)
SARS coronavirus (edit) The management of coronavirus infections with particular reference to SARS. (edit)
SARS coronavirus (edit) The newly emerged SARS-like coronavirus HCoV-EMC also has an "Achilles' heel": current effective inhibitor targeting a 3C-like protease (edit)
SARS coronavirus (edit) The nsp2 proteins of mouse hepatitis virus and SARS coronavirus are dispensable for viral replication. (edit)
SARS coronavirus (edit) The nucleocapsid protein of SARS-CoV induces transcription of hfgl2 prothrombinase gene dependent on C/EBP alpha. (edit)
SARS coronavirus (edit) The nucleocapsid protein of the SARS coronavirus is capable of self-association through a C-terminal 209 amino acid interaction domain. (edit)
SARS coronavirus (edit) The phylogeny of SARS coronavirus. (edit)
SARS coronavirus (edit) The replication of a mouse adapted SARS-CoV in a mouse cell line stably expressing the murine SARS-CoV receptor mACE2 efficiently induces the expression of proinflammatory cytokines (edit)
SARS coronavirus (edit) The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. (edit)
SARS coronavirus (edit) The role of severe acute respiratory syndrome (SARS)-coronavirus accessory proteins in virus pathogenesis (edit)
SARS coronavirus (edit) The route of inoculation determines the tissue tropism of modified vaccinia Tiantan expressing the spike glycoprotein of SARS-CoV in mice. (edit)
SARS coronavirus (edit) The secret life of ACE2 as a receptor for the SARS virus. (edit)
SARS coronavirus (edit) The severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct class of 5' to 3' viral helicases. (edit)
SARS coronavirus (edit) The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 (edit)
SARS coronavirus (edit) The spike protein of SARS-CoV--a target for vaccine and therapeutic development. (edit)
SARS coronavirus (edit) The spike protein of severe acute respiratory syndrome (SARS) is cleaved in virus infected Vero-E6 cells. (edit)
SARS coronavirus (edit) The structural characterization and antigenicity of the S protein of SARS-CoV. (edit)
SARS coronavirus (edit) The structure analysis and antigenicity study of the N protein of SARS-CoV. (edit)
SARS coronavirus (edit) The structure of a rigorously conserved RNA element within the SARS virus genome (edit)
SARS coronavirus (edit) Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)--possible lessons from a systematic review of SARS-CoV therapy. (edit)
SARS coronavirus (edit) Thermostability of the N-terminal RNA-binding domain of the SARS-CoV nucleocapsid protein: experiments and numerical simulations. (edit)
SARS coronavirus (edit) Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. (edit)
SARS coronavirus (edit) Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells. (edit)
SARS coronavirus (edit) Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication. (edit)
SARS coronavirus (edit) Topographic changes in SARS coronavirus-infected cells at late stages of infection (edit)
SARS coronavirus (edit) Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus. (edit)
SARS coronavirus (edit) Tracing SARS-coronavirus variant with large genomic deletion. (edit)
SARS coronavirus (edit) Tracing the SARS-coronavirus (edit)
SARS coronavirus (edit) Tracking the evolution of the SARS coronavirus using high-throughput, high-density resequencing arrays. (edit)
SARS coronavirus (edit) Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication (edit)
SARS coronavirus (edit) Transcriptional profiling of Vero E6 cells over-expressing SARS-CoV S2 subunit: insights on viral regulation of apoptosis and proliferation. (edit)
SARS coronavirus (edit) Transient oligomerization of the SARS-CoV N protein--implication for virus ribonucleoprotein packaging. (edit)
SARS coronavirus (edit) Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. (edit)
SARS coronavirus (edit) Travel implications of emerging coronaviruses: SARS and MERS-CoV. (edit)
SARS coronavirus (edit) Tryptophan-dependent membrane interaction and heteromerization with the internal fusion peptide by the membrane proximal external region of SARS-CoV spike protein. (edit)
SARS coronavirus (edit) Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). (edit)
SARS coronavirus (edit) Two strains of the SARS virus sequenced. (edit)
SARS coronavirus (edit) Two-amino acids change in the nsp4 of SARS coronavirus abolishes viral replication. (edit)
SARS coronavirus (edit) Two-way antigenic cross-reactivity between severe acute respiratory syndrome coronavirus (SARS-CoV) and group 1 animal CoVs is mediated through an antigenic site in the N-terminal region of the SARS-CoV nucleoprotein (edit)
SARS coronavirus (edit) Tyrosine dephosphorylation of STAT3 in SARS coronavirus-infected Vero E6 cells. (edit)
SARS coronavirus (edit) Ultrastructure of SARS-CoV, FIPV, and MHV revealed by electron cryomicroscopy. (edit)
SARS coronavirus (edit) Understanding bat SARS-like coronaviruses for the preparation of future coronavirus outbreaks - Implications for coronavirus vaccine development (edit)
SARS coronavirus (edit) Understanding the T cell immune response in SARS coronavirus infection (edit)
SARS coronavirus (edit) Unique SARS-CoV protein nsp1: bioinformatics, biochemistry and potential effects on virulence. (edit)
SARS coronavirus (edit) Unraveling the complexities of the interferon response during SARS-CoV infection (edit)
SARS coronavirus (edit) Update on SARS research and other possibly zoonotic coronaviruses. (edit)
SARS coronavirus (edit) Use of dual TaqMan probes to increase the sensitivity of 1-step quantitative reverse transcription-PCR: application to the detection of SARS coronavirus. (edit)
SARS coronavirus (edit) Using patient-collected clinical samples and sera to detect and quantify the severe acute respiratory syndrome coronavirus (SARS-CoV). (edit)
SARS coronavirus (edit) Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. (edit)
SARS coronavirus (edit) Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for severe acute respiratory syndrome coronavirus (SARS-CoV) (edit)
SARS coronavirus (edit) Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses. (edit)
SARS coronavirus (edit) Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants (edit)
SARS coronavirus (edit) Viral aetiology of acute respiratory illnesses in patients with a suspicion of severe acute respiratory syndrome (SARS) in Switzerland. (edit)
SARS coronavirus (edit) Viral evolution and the emergence of SARS coronavirus (edit)
SARS coronavirus (edit) Viral load and outcome in SARS infection: the role of personal protective equipment in the emergency department. (edit)
SARS coronavirus (edit) Viral load distribution in SARS outbreak (edit)
SARS coronavirus (edit) Viral load quantitation of SARS-coronavirus RNA using a one-step real-time RT-PCR. (edit)
SARS coronavirus (edit) Viral loads in clinical specimens and SARS manifestations. (edit)
SARS coronavirus (edit) Viral pathogens and acute lung injury: investigations inspired by the SARS epidemic and the 2009 H1N1 influenza pandemic (edit)
SARS coronavirus (edit) Virology. Researchers tie deadly SARS virus to bats. (edit)
SARS coronavirus (edit) Virology. The SARS coronavirus: a postgenomic era. (edit)
SARS coronavirus (edit) Virology: SARS virus infection of cats and ferrets. (edit)
SARS coronavirus (edit) Virtual screening for SARS-CoV protease based on KZ7088 pharmacophore points. (edit)
SARS coronavirus (edit) Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy. (edit)
SARS coronavirus (edit) Virtual screening of novel noncovalent inhibitors for SARS-CoV 3C-like proteinase. (edit)
SARS coronavirus (edit) Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses. (edit)
SARS coronavirus (edit) Virus Infection and Titration of SARS-CoV in Mouse Lung. (edit)
SARS coronavirus (edit) Virus detectives seek source of SARS in China's wild animals. (edit)
SARS coronavirus (edit) Virus-associated hemophagocytic syndrome in an international traveler as a differential diagnosis of SARS. (edit)
SARS coronavirus (edit) Virus-like particles of SARS-like coronavirus formed by membrane proteins from different origins demonstrate stimulating activity in human dendritic cells. (edit)
SARS coronavirus (edit) Virus-specific RNA and antibody from convalescent-phase SARS patients discharged from hospital. (edit)
SARS coronavirus (edit) Vitamin C and SARS coronavirus. (edit)
SARS coronavirus (edit) When animal viruses attack: SARS and avian influenza. (edit)
SARS coronavirus (edit) Why are HIV-1 fusion inhibitors not effective against SARS-CoV? Biophysical evaluation of molecular interactions. (edit)
SARS coronavirus (edit) Yeast based small molecule screen for inhibitors of SARS-CoV (edit)
SARS coronavirus (edit) Yeast expression and characterization of SARS-CoV N protein. (edit)
SARS coronavirus (edit) Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate. (edit)
SARS coronavirus (edit) ZCURVE_CoV: a new system to recognize protein coding genes in coronavirus genomes, and its applications in analyzing SARS-CoV genomes. (edit)
SARS coronavirus (edit) [A novel coronavirus---SARS virus]. (edit)
SARS coronavirus (edit) [A preliminary report of SARS coronavirus specific RNA in SARS convalescents and medical person]. (edit)
SARS coronavirus (edit) [A preliminary study of the structure prediction and expression of SARS-CoV spike protein]. (edit)
SARS coronavirus (edit) [A study of pulmonary inflammatory reaction induced by N-protein of SARS-CoV in rat models and effects of glucocorticoids on it]. (edit)
SARS coronavirus (edit) [Amplification and cloning of the N gene of SARS-associated coronavirus]. (edit)
SARS coronavirus (edit) [An epidemiological investigation of bats carrying SARS-CoV in Guangzhou and its vicinity]. (edit)
SARS coronavirus (edit) [An immunofluorescence assay for the detection of SARS associated coronavirus antibody based on recombinant nucleocapsid antigen and its application]. (edit)
SARS coronavirus (edit) [Analysis of false-positive associated with antibody tests for SARS-CoV in SLE patients]. (edit)
SARS coronavirus (edit) [Analysis on the SARS-CoV genome of PUMC01 isolate]. (edit)
SARS coronavirus (edit) [Antigenicity characterization of six different fragments of SARS-CoV N protein expressed in E. coli]. (edit)
SARS coronavirus (edit) [Clinical detection of polymerase gene of SARS-associated coronavirus]. (edit)
SARS coronavirus (edit) [Cloning of ACE-2 gene encoding the functional receptor for the SARS coronavirus and its expression in eukaryotic cells]. (edit)
SARS coronavirus (edit) [Cloning, expression and purification of SARS coronavirus PUMC2 strain nucleocapsid protein]. (edit)
SARS coronavirus (edit) [Cloning, purification, and antigenic characterization of three recombinant fragments derived from SARS-CoV S1 domain]. (edit)
SARS coronavirus (edit) [Comparative study of clinical characteristics and prognosis of clinically diagnosed SARS patients with positive and negative serum SARS coronavirus-specific antibodies test]. (edit)
SARS coronavirus (edit) [Comparison of serum biochemical features between SARS and other viral pneumonias]. (edit)
SARS coronavirus (edit) [Conditions for SARS-CoV cultivation and inactivation]. (edit)
SARS coronavirus (edit) [Construction and screening of SARS-CoV S protein-specific phage displayed antigen library]. (edit)
SARS coronavirus (edit) [Construction and screening of human phage antibody library against SARS virus]. (edit)
SARS coronavirus (edit) [Construction of a large human scFv library against SARS virus]. (edit)
SARS coronavirus (edit) [Construction of phage antibody library for Fab fragment from a convalescent patient infected with SARS coronavirus]. (edit)
SARS coronavirus (edit) [Detection for severe acute respiratory syndrome (SARS) coronavirus RNA in stool of SARS patients]. (edit)
SARS coronavirus (edit) [Detection of SARS coronavirus RNA]. (edit)
SARS coronavirus (edit) [Detection of SARS-CoV RNA in stool samples of SARS patients by nest RT-PCR and its clinical value]. (edit)
SARS coronavirus (edit) [Detection of SARS-associated coronavirus N protein by time-resolved fluoroimmunoassay]. (edit)
SARS coronavirus (edit) [Detection of SARS-coronavirus in both human and animals by RT-PCR]. (edit)
SARS coronavirus (edit) [Detection of the anti-SARS-coronavirus specific antibody levels in 156 SARS patients]. (edit)
SARS coronavirus (edit) [Detection of the mRNA expression of human angiotensin-converting enzyme 2 as a SARS coronavirus functional receptor in human femoral head]. (edit)
SARS coronavirus (edit) [Determination of SARS-CoV by simplified nested fluorescent RT-PCR]. (edit)
SARS coronavirus (edit) [Development and application of a safe SARS-CoV neutralization assay based on lentiviral vectors pseudotyped with SARS-CoV spike protein]. (edit)
SARS coronavirus (edit) [Development of monoclonal antibodies against SARS-CoV and identification of antigenic epitopes]. (edit)
SARS coronavirus (edit) [Development of the cDNA chip for SARS virus and a primary study on the possible molecular mechanism of interferon alpha2b inhibiting the SARS virus replication]. (edit)
SARS coronavirus (edit) [Effect of SARS-associated coronavirus on peripheral blood picture and liver function]. (edit)
SARS coronavirus (edit) [Enhanced-real time PCR: a highly sensitive method for SARS-coronavirus detection]. (edit)
SARS coronavirus (edit) [Expression and renaturation of a novel human single-chain Fv antibody against SARS-CoV]. (edit)
SARS coronavirus (edit) [Expression of SARS coronavirus nucleocapsid protein and construction of its DNA vaccine]. (edit)
SARS coronavirus (edit) [Expression of SARS-CoV in various types of cells in lung tissues]. (edit)
SARS coronavirus (edit) [Expression of predicted B cell epitope peptide in S2 subunit of SARS coronavirus spike protein in E.coli and identification of its mimic antigenicity]. (edit)
SARS coronavirus (edit) [Expression, purification and antibody preparation of recombinat SARS-CoV X5 protein]. (edit)
SARS coronavirus (edit) [Expression, purification and identification of recombinant SARS coronavirus membrane protein]. (edit)
SARS coronavirus (edit) [Follow up study on viruses associated with SARS among the SARS patients]. (edit)
SARS coronavirus (edit) [Gene prediction and function research of SARS-CoV(BJ01)]. (edit)
SARS coronavirus (edit) [Gene sequence analysis of SARS-associated coronavirus by nested RT-PCR]. (edit)
SARS coronavirus (edit) [Genetic variation analysis of SARS coronavirus]. (edit)
SARS coronavirus (edit) [High-efficiency expression of a receptor-binding domain of SARS-CoV spike protein in tobacco chloroplasts]. (edit)
SARS coronavirus (edit) [Human metapneumovirus pneumonia in an adult patient hospitalized for suspected severe acute respiratory syndrome (SARS)]. (edit)
SARS coronavirus (edit) [Identification and molecular cloning and sequence analysis of a novel coronavirus from patients with SARS by RT-PCR]. (edit)
SARS coronavirus (edit) [Identification of mimotope peptides which bind to the SARS-CoV spike protein specific monoclonal antibody 2C5 with phage-displayed peptides library]. (edit)
SARS coronavirus (edit) [Initial analysis of complete genome sequences of SARS coronavirus]. (edit)
SARS coronavirus (edit) [Modeling of the SARS coronavirus main proteinase and conformational flexibility of the active site]. (edit)
SARS coronavirus (edit) [Modified molecular beacon-based dual real-time PCR for detection of SARS virus and its application]. (edit)
SARS coronavirus (edit) [Optimization of expression condition of SARS-CoV PUPs genes in E. coli]. (edit)
SARS coronavirus (edit) [Over-expression in Escherichia coli and purification of nucleocaspid and membrane protein of SARS coronavirus]. (edit)
SARS coronavirus (edit) [Preparation of specific monoclonal antibody against nucleocapsid protein of SARS coronavirus]. (edit)
SARS coronavirus (edit) [Prokaryotic expression of S2 extracellular domain of SARS coronavirus spike protein and its fusion with Hela cell membrane]. (edit)
SARS coronavirus (edit) [Prokaryotic expression of SARS coronavirus spike protein and construction of its DNA vaccine]. (edit)
SARS coronavirus (edit) [RNase III-prepared short interfering RNAs induce degradation of SARS-coronavirus mRNAs in human cells]. (edit)
SARS coronavirus (edit) [Reliability of detecting SARS-CoV antibody for diagnosis of SARS]. (edit)
SARS coronavirus (edit) [SARS coronavirus]. (edit)
SARS coronavirus (edit) [SARS-CoV infection and pregnancy]. (edit)
SARS coronavirus (edit) [SARS-associated coronavirus gene fragments were detected from a suspected pediatric SARS patient]. (edit)
SARS coronavirus (edit) [SARS: a new paramyxovirus or coronavirus?]. (edit)
SARS coronavirus (edit) [Serological analysis of SARS Coronavirus in children diagnosed clinically as severe acute respiratory syndrome cases during SARS epidemic in Beijing]. (edit)
SARS coronavirus (edit) [Some medical staff positive for serum SARS coronavirus antibody IgG have only mild symptoms]. (edit)
SARS coronavirus (edit) [Study on the RNA of severe acute respiratory syndrome (SARS) associated coronavirus in the blood and excretion of convalescent patients with SARS]. (edit)
SARS coronavirus (edit) [Study on the changing regularity of special antibody and expression of stomach and enteric involvement on SARS-coronavirus infection in the recovery period of severe acute respiratory syndrome]. (edit)
SARS coronavirus (edit) [The biological characteristics of SARS virus and its related coronaviruses]. (edit)
SARS coronavirus (edit) [The cloning, expression, purification and identification of SARS virus S2 gene and study on its immunological characteristics]. (edit)
SARS coronavirus (edit) [The expression and activity detection of a variant N protein of SARS-CoV]. (edit)
SARS coronavirus (edit) [The genome comparison of SARS-CoV and other coronaviruses]. (edit)
SARS coronavirus (edit) [Variability analysis of S2 gene of SARS-CoV]. (edit)
SARS coronavirus (edit) [Why viral (SARS, Ebola and AIDS) epidemics now?]. (edit)
SARS coronavirus (edit) [cDNAs cloning of SARS-CoV PUMC2 viral genome]. (edit)
SARS coronavirus (edit) siRNA targeting the leader sequence of SARS-CoV inhibits virus replication. (edit)
SARS coronavirus (edit) siRNAs targeting terminal sequences of the SARS-associated coronavirus membrane gene inhibit M protein expression through degradation of M mRNA. (edit)
SARS-CoV-2 (edit) A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) (edit)
SARS-CoV-2 (edit) Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 (edit)
SARS-CoV-2 (edit) Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 (edit)
SARS-CoV-2 (edit) Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 (edit)
SARS-CoV-2 (edit) Autopsy in suspected COVID-19 cases (edit)
SARS-CoV-2 (edit) Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein (edit)
SARS-CoV-2 (edit) Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs (edit)
SARS-CoV-2 (edit) COVID-19 pneumonia: what has CT taught us? (edit)
SARS-CoV-2 (edit) Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR (edit)
SARS-CoV-2 (edit) Chemokine Regulation During Epidemic Coronavirus Infection (edit)
SARS-CoV-2 (edit) Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past (edit)
SARS-CoV-2 (edit) Comparative dynamic aerosol efficiencies of three emergent coronaviruses and the unusual persistence of SARS-CoV-2 in aerosol suspensions (edit)
SARS-CoV-2 (edit) Comparing the Binding Interactions in the Receptor Binding Domains of SARS-CoV-2 and SARS-CoV (edit)
SARS-CoV-2 (edit) Developing antibody tests for SARS-CoV-2 (edit)
SARS-CoV-2 (edit) Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV (edit)
SARS-CoV-2 (edit) Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 (edit)
SARS-CoV-2 (edit) Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera (edit)
SARS-CoV-2 (edit) Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic (edit)
SARS-CoV-2 (edit) Exaggerated risk of transmission of COVID-19 by fomites (edit)
SARS-CoV-2 (edit) From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes (edit)
SARS-CoV-2 (edit) Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses (edit)
SARS-CoV-2 (edit) High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa (edit)
SARS-CoV-2 (edit) Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2 (edit)
SARS-CoV-2 (edit) Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV (edit)
SARS-CoV-2 (edit) Interaction between RAAS inhibitors and ACE2 in the context of COVID-19 (edit)
SARS-CoV-2 (edit) Mechanisms of Coronavirus Nsp1-Mediated Control of Host and Viral Gene Expression (edit)
SARS-CoV-2 (edit) Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV (edit)
SARS-CoV-2 (edit) Mystery deepens over animal source of coronavirus (edit)
SARS-CoV-2 (edit) Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV (edit)
SARS-CoV-2 (edit) Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review (edit)
SARS-CoV-2 (edit) Preparing for emerging respiratory pathogens such as SARS-CoV, MERS-CoV, and SARS-CoV-2 (edit)
SARS-CoV-2 (edit) Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus (edit)
SARS-CoV-2 (edit) Reply to: 'Interaction between RAAS inhibitors and ACE2 in the context of COVID-19' (edit)
SARS-CoV-2 (edit) Sarbecovirus comparative genomics elucidates gene content of SARS-CoV-2 and functional impact of COVID-19 pandemic mutations (edit)
SARS-CoV-2 (edit) Serial co-expression analysis of host factors from SARS-CoV viruses highly converges with former high-throughput screenings and proposes key regulators (edit)
SARS-CoV-2 (edit) Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses (edit)
SARS-CoV-2 (edit) Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group (edit)
SARS-CoV-2 (edit) Shifts in global bat diversity suggest a possible role of climate change in the emergence of SARS-CoV-1 and SARS-CoV-2 (edit)
SARS-CoV-2 (edit) The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis (edit)
SARS-CoV-2 (edit) The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2 (edit)
SARS-CoV-2 (edit) The proximal origin of SARS-CoV-2 (edit)
SARS-CoV-2 (edit) The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 (edit)
SARS-CoV-2 (edit) [Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.] (edit)
SARS-CoV-2 (edit) [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).] (edit)

Ejemplos de código

curl

curl -s https://raw.githubusercontent.com/egonw/SARS-CoV-2-Queries/master/sparql/compareViruses.rq | sed 's+<lang/>+es+' > compareViruses.rq

curl -H "Accept: text/tab-separated-values" -G https://query.wikidata.org/bigdata/namespace/wdq/sparql --data-urlencode query@compareViruses.rq

Esta consulta SPARQL está disponible en CCZero.